[
    {
        "idx": 1309,
        "sentence": "Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .",
        "label": {
            "cruciform DNA": "DNA",
            "HMG boxes": "protein",
            "cross-over DNA": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample2: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample3: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample4: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample5: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample6: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample7: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample8: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample9: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample10: Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\nTRFs set: ['promoter', 'activation', 'mRNA', 'kinase', 'genes']\n>>>\nExample11: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample12: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample13: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n>>>\nExample14: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample15: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample16: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .\nAnswer:\n"
    },
    {
        "idx": 228,
        "sentence": "We have carried out experiments to define the nature of the higher affinity CVZ binding site .",
        "label": {
            "higher affinity CVZ binding site": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample2: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample3: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample4: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample5: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample6: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample7: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample8: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample9: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample10: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample11: Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .\nTRFs set: ['gene', 'enhancer', 'genes', 'mRNA', 'promoter']\n>>>\nExample12: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample13: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample14: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample15: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample16: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We have carried out experiments to define the nature of the higher affinity CVZ binding site .\nAnswer:\n"
    },
    {
        "idx": 51,
        "sentence": "Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.",
        "label": {
            "T-cell determinants": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample2: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample5: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample6: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample7: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample8: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample9: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample10: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample11: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample12: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample13: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample14: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample15: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample16: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.\nAnswer:\n"
    },
    {
        "idx": 1518,
        "sentence": "Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .",
        "label": {
            "nuclear calcium/calmodulin-dependent protein kinase II": "protein",
            "human B lymphocytes": "cell_type",
            "Anti-immunoglobulin M": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample2: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample3: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample4: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample5: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample6: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample9: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample10: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample11: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample12: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample13: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample14: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample15: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample16: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .\nAnswer:\n"
    },
    {
        "idx": 563,
        "sentence": "The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .",
        "label": {
            "PDGF(B)": "protein",
            "PDGF(B) mRNA": "RNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample2: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n>>>\nExample3: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample4: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample7: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample8: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample9: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample12: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample13: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample14: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample15: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample16: Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'cells', 'blood']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .\nAnswer:\n"
    },
    {
        "idx": 501,
        "sentence": "Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .",
        "label": {
            "CCRF-CEM": "cell_line",
            "TCF-1 alpha": "protein",
            "nonlymphoid (HeLa) cell lines": "cell_line",
            "mature B cells": "cell_line",
            "JY": "cell_line",
            "Namalwa": "cell_line",
            "57- to 53-kD proteins": "protein",
            "Jurkat": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample2: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample5: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample6: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample7: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample10: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample11: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample12: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample13: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample14: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample15: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample16: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .\nAnswer:\n"
    },
    {
        "idx": 457,
        "sentence": "TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .",
        "label": {
            "T lymphocytes": "cell_type",
            "TAR": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample4: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample5: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample6: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample7: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample8: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample11: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample12: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample13: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample14: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample15: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample16: Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'genes', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .\nAnswer:\n"
    },
    {
        "idx": 285,
        "sentence": "ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .",
        "label": {
            "ER": "protein",
            "lymphocyte DNA": "DNA",
            "lymphocytes": "cell_type",
            "lymphocyte cytosolic protein": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample2: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample5: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample8: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample9: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample12: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample13: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample14: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample15: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample16: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .\nAnswer:\n"
    },
    {
        "idx": 1508,
        "sentence": "Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "B cell-specific coactivator": "protein",
            "murine homolog": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample2: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample3: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample4: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample5: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample8: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample9: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample10: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample11: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample12: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample13: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample14: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample15: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample16: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .\nAnswer:\n"
    },
    {
        "idx": 209,
        "sentence": "Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.",
        "label": {
            "lymphoblastoid cell line": "cell_line",
            "IM-9": "cell_line",
            "type-II EBS": "protein",
            "Type-II estrogen -binding sites": "protein",
            "human lymphoblastoid cell line": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample2: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample3: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample4: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample5: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample8: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample9: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample10: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample11: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample12: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample13: Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'cells', 'leukocytes']\n>>>\nExample14: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample15: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample16: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.\nAnswer:\n"
    },
    {
        "idx": 1385,
        "sentence": "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.",
        "label": {
            "LTR": "DNA",
            "HIV-1 LTR": "DNA",
            "C/EBP sites": "DNA",
            "C/EBP site": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample2: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample3: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample4: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample5: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample6: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample9: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample10: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample11: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample12: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n>>>\nExample13: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample14: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample15: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample16: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.\nAnswer:\n"
    },
    {
        "idx": 1516,
        "sentence": "Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "GAL4 DNA binding domain": "protein",
            "COOH-terminal domain": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample2: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample3: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample4: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample7: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample8: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample9: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample10: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample11: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample12: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n>>>\nExample13: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n>>>\nExample14: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample15: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample16: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .\nAnswer:\n"
    },
    {
        "idx": 1827,
        "sentence": "A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .",
        "label": {
            "human interleukin 2 gene promoter": "DNA",
            "EGR-1": "protein",
            "Sp1": "protein",
            "regulatory element": "DNA",
            "binding site": "DNA",
            "zinc finger proteins": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample2: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample6: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample7: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample8: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample9: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample10: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample11: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample12: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample13: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample14: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample15: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample16: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .\nAnswer:\n"
    },
    {
        "idx": 1116,
        "sentence": "The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .",
        "label": {
            "thymocytes": "cell_type",
            "p53": "protein",
            "mitogen-activated mature T lymphocytes": "cell_line",
            "tumour suppressor p53": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample2: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample3: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample4: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample5: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample6: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample9: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample10: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample11: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample12: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample13: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample14: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample15: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample16: The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.\nTRFs set: ['cells', 'cell', 'macrophages', 'blood', 'leukocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .\nAnswer:\n"
    },
    {
        "idx": 178,
        "sentence": "T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .",
        "label": {
            "T lymphocytes": "cell_type",
            "lavage cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample2: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample3: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample4: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample5: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample6: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample7: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample8: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample9: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample10: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample11: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample12: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample13: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample14: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample15: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample16: Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'cells', 'leukocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .\nAnswer:\n"
    },
    {
        "idx": 1209,
        "sentence": "A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample2: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample3: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample4: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample5: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample6: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample7: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample8: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample9: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample10: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample11: Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'activation', 'cells']\n>>>\nExample12: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample13: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n>>>\nExample14: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n>>>\nExample15: In apparent contradiction, expression of a dominant negative form of Ras , RasN17 , also inhibited IL-2 -induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'activation', 'genes']\n>>>\nExample16: The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults .\nTRFs set: ['patients', 'peripheral', 'thymocytes', 'cells', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .\nAnswer:\n"
    },
    {
        "idx": 864,
        "sentence": "Differences in transcriptional enhancers of HIV-1 and HIV-2 .",
        "label": {
            "transcriptional enhancers": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample2: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample3: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample4: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample9: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample12: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample13: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample14: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample15: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample16: NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\nTRFs set: ['promoter', 'mRNA', 'enhancer', 'gene', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Differences in transcriptional enhancers of HIV-1 and HIV-2 .\nAnswer:\n"
    },
    {
        "idx": 65,
        "sentence": "Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .",
        "label": {
            "promoter": "DNA",
            "PRDII element": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample2: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample3: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample4: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample5: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample6: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample7: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample8: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample9: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample10: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample11: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample12: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample13: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample14: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample15: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample16: Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\nTRFs set: ['kinase', 'tyrosine', 'lymphocytes', 'thymocytes', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .\nAnswer:\n"
    },
    {
        "idx": 61,
        "sentence": "From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.",
        "label": {
            "82": "protein",
            "43-47 kD": "protein",
            "major protein": "protein",
            "T-cells": "cell_type",
            "minor proteins": "protein",
            "67": "protein",
            "HeLa cells": "cell_line",
            "52 kD": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample2: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample3: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample6: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample7: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample8: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample9: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample12: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample13: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample14: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample15: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample16: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.\nAnswer:\n"
    },
    {
        "idx": 191,
        "sentence": "A block to RNA elongation is largely responsible for decreased c-myc transcription .",
        "label": {
            "c-myc": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A block to RNA elongation is largely responsible for decreased c-myc transcription .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample2: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample3: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample4: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample5: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample6: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample7: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample10: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample11: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample12: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample13: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample14: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample15: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample16: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A block to RNA elongation is largely responsible for decreased c-myc transcription .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A block to RNA elongation is largely responsible for decreased c-myc transcription .\nAnswer:\n"
    },
    {
        "idx": 447,
        "sentence": "Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.",
        "label": {
            "enhancer": "DNA",
            "binding site": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample2: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample3: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample4: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample5: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample6: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample7: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample10: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample11: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample12: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample13: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample14: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample15: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample16: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.\nAnswer:\n"
    },
    {
        "idx": 476,
        "sentence": "A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .",
        "label": {
            "protooncogenes": "DNA",
            "immediate early response genes": "DNA",
            "growth factor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample2: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample3: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample6: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample7: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample8: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample9: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample10: The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'RNAs']\n>>>\nExample11: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample12: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample13: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample14: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample15: Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\nTRFs set: ['promoter', 'activation', 'mRNA', 'kinase', 'genes']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .\nAnswer:\n"
    },
    {
        "idx": 1034,
        "sentence": "p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .",
        "label": {
            "Stat1": "protein",
            "phosphorylation site": "protein",
            "Src homology 2 (SH2) domain": "protein",
            "p94": "protein",
            "p95": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample2: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample3: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample6: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample7: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample8: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample9: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample10: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample11: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample12: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample13: Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\nTRFs set: ['kinase', 'phosphorylation', 'neutrophils', 'promonocytic', 'enhancer']\n>>>\nExample14: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample15: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample16: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .\nAnswer:\n"
    },
    {
        "idx": 1232,
        "sentence": "IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).",
        "label": {
            "IBR": "protein",
            "transcription factors": "protein",
            "erected wing gene product": "protein",
            "human NRF-1/alpha-Pal factor": "protein",
            "EWG": "protein",
            "P3A2": "protein",
            "503-amino-acid-long acidic protein": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample2: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: A novel interferon regulatory factor family transcription factor , ICSAT/Pip/LSIRF , that negatively regulates the activity of interferon-regulated genes .\nTRFs set: ['kinase', 'RNAs', 'promoter', 'mRNA', 'enhancer']\n>>>\nExample5: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample6: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample7: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample10: Like Drosophila Toll , human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat ( LRR ) domain , and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor .\nTRFs set: ['mRNA', 'kinase', 'cells', 'cell', 'tyrosine']\n>>>\nExample11: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample12: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample13: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample14: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample15: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample16: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).\nAnswer:\n"
    },
    {
        "idx": 54,
        "sentence": "Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .",
        "label": {
            "LTR": "DNA",
            "human T-cell types": "cell_type",
            "T-cell types": "cell_type",
            "element": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample2: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample3: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample4: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample7: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample8: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample9: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample10: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample11: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample12: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample13: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample14: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample15: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample16: Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'genes', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .\nAnswer:\n"
    },
    {
        "idx": 1149,
        "sentence": "The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .",
        "label": {
            "Sp1": "protein",
            "DCs": "cell_type",
            "NF-kappa B": "protein",
            "T cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample2: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample3: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample4: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample5: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample6: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample7: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample8: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample9: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample10: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample11: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample12: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample13: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample14: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample15: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample16: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .\nAnswer:\n"
    },
    {
        "idx": 407,
        "sentence": "Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .",
        "label": {
            "VDR": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample2: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample3: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample4: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample5: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample6: Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\nTRFs set: ['lymphocytes', 'leukocytes', 'tyrosine', 'thymocytes', 'blood']\n>>>\nExample7: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample8: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample9: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample10: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample11: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample12: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample13: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample14: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample15: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample16: Furthermore, the two VDR 3'-UTR haplotypes conferred an identical half-life on a heterologous beta-globin reporter gene , in an in vitro assay .\nTRFs set: ['gene', 'mRNA', 'RNAs', 'genes', 'clones']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .\nAnswer:\n"
    },
    {
        "idx": 1466,
        "sentence": "As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .",
        "label": {
            "endothelial cells": "cell_type",
            "NFAT": "protein",
            "activated endothelial cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample2: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample3: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample4: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample5: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample6: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample7: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample8: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample9: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample10: Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\nTRFs set: ['kinase', 'neutrophils', 'activation', 'NF', 'macrophages']\n>>>\nExample11: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample12: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample13: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample14: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample15: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample16: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .\nAnswer:\n"
    },
    {
        "idx": 1330,
        "sentence": "Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .",
        "label": {
            "I kappa B alpha": "protein",
            "I kappa B": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample2: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample3: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample4: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample5: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample6: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample7: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample8: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample9: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample10: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample11: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample12: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample13: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample14: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample15: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample16: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .\nAnswer:\n"
    },
    {
        "idx": 1436,
        "sentence": "Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .",
        "label": {
            "hTR beta 1 mRNA": "RNA",
            "hTR beta 1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample2: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample3: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample4: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample5: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample6: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample7: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample8: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample9: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample10: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample13: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample14: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample15: Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'cells', 'leukocytes']\n>>>\nExample16: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .\nAnswer:\n"
    },
    {
        "idx": 859,
        "sentence": "We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .",
        "label": {
            "inducible": "protein",
            "Jurkat cells": "cell_line",
            "C1": "protein",
            "HIV enhancer": "DNA",
            "C2": "protein",
            "constitutive, C2 , protein": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample2: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample3: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample4: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample5: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample6: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample7: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample10: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample11: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample12: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample13: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample14: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample15: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample16: Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\nTRFs set: ['HeLa', 'cells', 'gene', 'genes', 'cell']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .\nAnswer:\n"
    },
    {
        "idx": 451,
        "sentence": "However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .",
        "label": {
            "NF-muE3": "protein",
            "B cells": "cell_type",
            "lymphoid cells": "cell_type",
            "transfected reporter gene": "DNA",
            "Ig heavy chain enhancer": "DNA",
            "non- lymphoid cells": "cell_type",
            "non-B cells": "cell_type",
            "endogenous Ig heavy chain enhancer": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample2: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample5: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample6: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample7: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample8: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample9: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample12: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample13: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample14: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample15: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample16: Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'activation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .\nAnswer:\n"
    },
    {
        "idx": 919,
        "sentence": "The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .",
        "label": {
            "56-kDa protein": "protein",
            "p56": "protein",
            "EC1 antibody": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample2: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample5: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample6: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample7: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample8: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample9: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample10: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample11: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample12: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample13: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample14: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample15: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample16: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .\nAnswer:\n"
    },
    {
        "idx": 1206,
        "sentence": "In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.",
        "label": {
            "androgen receptors": "protein",
            "mononuclear leukocytes": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample2: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample3: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample4: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample5: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample6: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample7: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample8: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample9: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample10: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample11: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample12: These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'mRNA', 'lymphocytes']\n>>>\nExample13: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample14: Mononuclear phagocytes are exposed to fibrinous provisional matrix throughout migration into inflammatory foci, so this study was undertaken to determine whether fibrinogen triggers activation of NF-kappa B transcription factors .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample15: Regulation and specificity of MNDA expression in monocytes , macrophages , and leukemia/B lymphoma cell lines .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'lymphocytes', 'leukocytes']\n>>>\nExample16: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.\nAnswer:\n"
    },
    {
        "idx": 569,
        "sentence": "In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .",
        "label": {
            "PDGF(B)": "protein",
            "EGR2": "DNA",
            "c-jun": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample2: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample3: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample4: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample5: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample6: Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\nTRFs set: ['kinase', 'phosphorylation', 'neutrophils', 'promonocytic', 'enhancer']\n>>>\nExample7: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample8: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample9: The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'RNAs']\n>>>\nExample10: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample11: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample12: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample13: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample14: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample15: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample16: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .\nAnswer:\n"
    },
    {
        "idx": 1657,
        "sentence": "HMG-I binds to GATA motifs : implications for an HPFH syndrome .",
        "label": {
            "HMG-I": "protein",
            "GATA motifs": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample2: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample3: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample4: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample5: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample6: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample7: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample8: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample11: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample12: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample13: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample14: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample15: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample16: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: HMG-I binds to GATA motifs : implications for an HPFH syndrome .\nAnswer:\n"
    },
    {
        "idx": 1780,
        "sentence": "Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .",
        "label": {
            "Id3": "protein",
            "Mo": "cell_line",
            "Id2": "protein",
            "4/5 T-cell lines": "cell_line",
            "S-LB1": "cell_line",
            "MT-2": "cell_line",
            "ATL-1k": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample2: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample3: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample4: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample5: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample6: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample9: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample10: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample11: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample12: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample13: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample14: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample15: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample16: Expression of either the TCL1 oncogene , or transcripts from its homologue MTCP1/c6.1B , in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'cells', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .\nAnswer:\n"
    },
    {
        "idx": 13,
        "sentence": "We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.",
        "label": {
            "platelet-activating factor": "protein",
            "B cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample2: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample3: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample4: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample5: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample6: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample7: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample8: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample9: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample10: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample11: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample12: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample13: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample14: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample15: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample16: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.\nAnswer:\n"
    },
    {
        "idx": 1554,
        "sentence": "The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .",
        "label": {
            "GP": "protein",
            "normal platelets": "cell_type",
            "cis-acting elements": "DNA",
            "GP Ib alpha": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample2: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample3: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample4: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample5: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample6: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample7: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample8: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample9: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample10: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample11: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample12: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample13: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample14: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample15: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample16: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .\nAnswer:\n"
    },
    {
        "idx": 1650,
        "sentence": "This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .",
        "label": {
            "PU.1": "protein",
            "myeloid PU.1 binding site": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample2: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample3: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample4: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample5: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample6: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample9: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample10: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample11: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample12: This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .\nTRFs set: ['kinase', 'monocytes', 'promonocytic', 'mRNA', 'macrophages']\n>>>\nExample13: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample14: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample15: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample16: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .\nAnswer:\n"
    },
    {
        "idx": 326,
        "sentence": "We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .",
        "label": {
            "EB1": "protein",
            "R-responsive element": "DNA",
            "HeLa cells": "cell_line",
            "domain B": "DNA",
            "EB1 -responsive B-cell-specific element": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample2: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample6: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample7: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample8: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample9: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample10: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample11: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample12: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample13: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample14: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample15: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .\nAnswer:\n"
    },
    {
        "idx": 1429,
        "sentence": "Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .",
        "label": {
            "TR": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample2: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample3: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample4: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample5: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample6: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample7: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample8: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample9: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample10: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample11: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample12: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample13: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample14: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample15: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .\nAnswer:\n"
    },
    {
        "idx": 865,
        "sentence": "Response to T cell activation signals .",
        "label": {
            "T cell": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Response to T cell activation signals .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample2: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample3: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample4: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample5: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample6: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample7: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample8: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample9: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample10: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample11: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample12: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample13: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample14: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample15: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample16: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Response to T cell activation signals .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Response to T cell activation signals .\nAnswer:\n"
    },
    {
        "idx": 696,
        "sentence": "First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .",
        "label": {
            "TRE -DNA fragment": "DNA",
            "nuclear proteins": "protein",
            "TRE": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample3: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample6: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample7: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample8: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample9: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample10: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample11: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample12: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample13: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample14: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample15: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample16: Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\nTRFs set: ['HeLa', 'cells', 'gene', 'genes', 'cell']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .\nAnswer:\n"
    },
    {
        "idx": 318,
        "sentence": "Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.",
        "label": {
            "estrogen receptor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample2: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample3: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample6: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample7: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample8: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample9: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample10: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample11: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample12: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample13: Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population , while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\nTRFs set: ['promonocytic', 'monocytes', 'kinase', 'lymphocytes', 'thymocytes']\n>>>\nExample14: Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1 .\nTRFs set: ['phosphorylation', 'promoter', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample15: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n>>>\nExample16: The predominant E2F complex in human primary haemopoietic cells and in AML blasts contains E2F-4 , DP-1 and p130 .\nTRFs set: ['promonocytic', 'kinase', 'lymphocytes', 'cells', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.\nAnswer:\n"
    },
    {
        "idx": 440,
        "sentence": "All three proteins show the same sequence specificity and binding affinity .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'All three proteins show the same sequence specificity and binding affinity .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: These two related genes share the evolutionarily conserved region encoding the Runt domain .\nTRFs set: ['genes', 'gene', 'kinase', 'RNAs', 'mRNA']\n>>>\nExample2: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample3: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample4: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample5: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample6: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample7: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample8: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample9: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample10: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample11: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample12: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample13: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample14: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample15: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample16: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'All three proteins show the same sequence specificity and binding affinity .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: All three proteins show the same sequence specificity and binding affinity .\nAnswer:\n"
    },
    {
        "idx": 1563,
        "sentence": "Pathogenesis of atherosclerosis .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Pathogenesis of atherosclerosis .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'endobronchial', 'gene']\n>>>\nExample2: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample3: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample4: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample5: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample6: Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes .\nTRFs set: ['monocytes', 'macrophages', 'kinase', 'blood', 'cells']\n>>>\nExample7: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample8: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample9: Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\nTRFs set: ['kinase', 'neutrophils', 'activation', 'NF', 'macrophages']\n>>>\nExample10: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample11: Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample12: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample13: Eosinophils play an important role in the effector phase of allergic inflammation .\nTRFs set: ['lymphocytes', 'neutrophils', 'leukocytes', 'macrophages', 'monocytes']\n>>>\nExample14: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample15: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample16: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Pathogenesis of atherosclerosis .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Pathogenesis of atherosclerosis .\nAnswer:\n"
    },
    {
        "idx": 689,
        "sentence": "High-risk patients can be recognized morphologically.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'High-risk patients can be recognized morphologically.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.\nTRFs set: ['promonocytic', 'lymphocytes', 'monocytes', 'macrophages', 'mRNA']\n>>>\nExample2: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample3: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample4: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample5: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample6: Additionally, mutated Ras can also serve as a primary target for the development of immunotherapy or drug therapy .\nTRFs set: ['kinase', 'gene', 'tyrosine', 'genes', 'cells']\n>>>\nExample7: By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\nTRFs set: ['clones', 'gene', 'genes', 'cells', 'phosphorylation']\n>>>\nExample8: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample9: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample10: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample11: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample12: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample13: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample14: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample15: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample16: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'High-risk patients can be recognized morphologically.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: High-risk patients can be recognized morphologically.\nAnswer:\n"
    },
    {
        "idx": 189,
        "sentence": "Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .",
        "label": {
            "human T lymphoblastic tumor cell line": "cell_line",
            "c-myc": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample2: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample3: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample4: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample5: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample6: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample7: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample8: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample9: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample10: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample11: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample12: Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\nTRFs set: ['kinase', 'tyrosine', 'lymphocytes', 'thymocytes', 'gene']\n>>>\nExample13: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample14: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample15: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample16: These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT .\nTRFs set: ['cells', 'kinase', 'thymocytes', 'activation', 'cell']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .\nAnswer:\n"
    },
    {
        "idx": 778,
        "sentence": "Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .",
        "label": {
            "OTF-1": "protein",
            "pre-B cells": "cell_line",
            "immunoglobulin gene": "DNA",
            "HeLa cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample4: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample5: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample6: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample7: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample8: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample9: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample10: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample11: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample12: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample13: T cell blasts treated with PMA are now responsive to IFN-gamma .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'macrophages']\n>>>\nExample14: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample15: Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\nTRFs set: ['HeLa', 'cells', 'gene', 'genes', 'cell']\n>>>\nExample16: Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .\nTRFs set: ['kinase', 'lymphocytes', 'enhancer', 'promonocytic', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .\nAnswer:\n"
    },
    {
        "idx": 198,
        "sentence": "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample2: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample3: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample4: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample5: Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\nTRFs set: ['kinase', 'lymphocytes', 'promonocytic', 'promoter', 'thymocytes']\n>>>\nExample6: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample7: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample8: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample9: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample10: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample11: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample12: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample13: T cell blasts treated with PMA are now responsive to IFN-gamma .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'macrophages']\n>>>\nExample14: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample15: Expression of either the TCL1 oncogene , or transcripts from its homologue MTCP1/c6.1B , in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'cells', 'kinase']\n>>>\nExample16: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.\nAnswer:\n"
    },
    {
        "idx": 735,
        "sentence": "This prompted us to analyze the octamer-binding proteins in the latter cells.",
        "label": {
            "octamer-binding proteins": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This prompted us to analyze the octamer-binding proteins in the latter cells.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample2: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample3: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample4: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample7: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample8: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample9: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample10: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample11: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample12: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample13: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample14: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample15: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample16: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This prompted us to analyze the octamer-binding proteins in the latter cells.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This prompted us to analyze the octamer-binding proteins in the latter cells.\nAnswer:\n"
    },
    {
        "idx": 1735,
        "sentence": "We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .",
        "label": {
            "VDR": "protein",
            "IL-2 promoter/reporter constructs": "DNA",
            "Jurkat cells": "cell_line",
            "VDR overexpression vector": "DNA",
            "IL-2": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample3: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample6: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample7: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample8: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample9: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample10: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample11: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample12: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample13: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample14: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample15: While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\nTRFs set: ['kinase', 'promoter', 'phosphorylation', 'activation', 'enhancer']\n>>>\nExample16: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .\nAnswer:\n"
    },
    {
        "idx": 704,
        "sentence": "Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .",
        "label": {
            "ubiquitous and developmentally regulated proteins": "protein",
            "ubiquitous": "protein",
            "developmentally regulated proteins": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample2: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample3: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample4: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample5: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample6: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample9: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample10: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample11: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample12: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample13: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample14: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample15: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample16: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .\nAnswer:\n"
    },
    {
        "idx": 1236,
        "sentence": "Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .",
        "label": {
            "direct-repeat palindrome": "DNA",
            "IBR/F": "protein",
            "IBR/F binding sites": "DNA",
            "optimal site": "DNA",
            "alternating RCGCRYGCGY consensus": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample2: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample3: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample4: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample5: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample6: Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .\nTRFs set: ['gene', 'enhancer', 'genes', 'mRNA', 'promoter']\n>>>\nExample7: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample8: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample9: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample12: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample13: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample14: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample15: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n>>>\nExample16: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .\nAnswer:\n"
    },
    {
        "idx": 541,
        "sentence": "To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample2: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample3: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample4: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample5: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample6: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample7: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample8: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample9: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample10: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample11: Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample12: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample13: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample16: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.\nAnswer:\n"
    },
    {
        "idx": 1652,
        "sentence": "Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.",
        "label": {
            "PU.1": "protein",
            "PU-SF complex": "protein",
            "myeloid promoters": "DNA",
            "PU.1 site": "DNA",
            "PU-SF": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample2: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample3: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample4: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample5: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample6: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample7: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample8: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample9: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample10: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample11: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample12: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample13: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample14: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample15: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample16: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.\nAnswer:\n"
    },
    {
        "idx": 88,
        "sentence": "TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .",
        "label": {
            "TNF alpha": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample2: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample3: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample4: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample5: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample6: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample7: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample10: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample11: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample12: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample13: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample14: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample15: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample16: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .\nAnswer:\n"
    },
    {
        "idx": 1494,
        "sentence": "Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .",
        "label": {
            "latent NF-kappa B": "protein",
            "cytokine": "protein",
            "NF-kappa B": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample2: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample3: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample4: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample5: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample6: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample7: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample8: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample9: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample10: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample11: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample12: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample13: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample14: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample15: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample16: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .\nAnswer:\n"
    },
    {
        "idx": 940,
        "sentence": "Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .",
        "label": {
            "PBMC": "cell_type",
            "type II EBS": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample2: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample3: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample4: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample5: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample6: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample7: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample8: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample9: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample10: Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\nTRFs set: ['lymphocytes', 'leukocytes', 'tyrosine', 'thymocytes', 'blood']\n>>>\nExample11: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample12: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample13: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample14: Transforming growth factor-beta ( TGF-beta ) inhibits B cell Ig secretion and reduces B cell membrane Ig expression .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'mRNA', 'cells']\n>>>\nExample15: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample16: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .\nAnswer:\n"
    },
    {
        "idx": 1098,
        "sentence": "Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .",
        "label": {
            "microtubules": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample2: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample3: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample4: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample5: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample6: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample7: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample8: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample9: Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'RNAs', 'cell']\n>>>\nExample10: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample11: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample12: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample13: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample14: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample15: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample16: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .\nAnswer:\n"
    },
    {
        "idx": 255,
        "sentence": "c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.",
        "label": {
            "c-myc RNA": "RNA",
            "RWLeu-4 cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample2: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample3: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample4: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample5: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample6: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample7: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample8: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample9: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample10: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample11: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample12: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample13: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample14: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample15: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample16: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.\nAnswer:\n"
    },
    {
        "idx": 775,
        "sentence": "Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.",
        "label": {
            "OTF-1": "protein",
            "OTF-2": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample2: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample3: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample4: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample7: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample8: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample9: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample10: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample11: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample12: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample13: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample14: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample15: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample16: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.\nAnswer:\n"
    },
    {
        "idx": 161,
        "sentence": "Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample2: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample3: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample4: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample5: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample6: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample7: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample8: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample9: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample10: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample11: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample12: MATERIALS AND METHODS: Human monocytes were stimulated with PMA (50 ng/ml) alone or LPS (100 ng/ml) with and without a nonspecific serine /threonine protein kinase inhibitor staurosporine (Stauro), a specific pan- PKC inhibitor bisindolylmaleimide ( Bis ), or an inhibitor of PTK genistein ( Gen ).\nTRFs set: ['monocytes', 'kinase', 'promonocytic', 'phosphorylation', 'macrophages']\n>>>\nExample13: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample14: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n>>>\nExample15: DNA-binding phosphoproteins induced after T cell activation : effects of cyclosporin A .\nTRFs set: ['phosphorylation', 'kinase', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample16: Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population , while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\nTRFs set: ['promonocytic', 'monocytes', 'kinase', 'lymphocytes', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.\nAnswer:\n"
    },
    {
        "idx": 1130,
        "sentence": "B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .",
        "label": {
            "B-lymphoblastoid cell lines": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample2: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample3: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample4: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample5: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample6: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample7: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample8: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample9: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample10: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample11: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample12: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample13: Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\nTRFs set: ['blood', 'cells', 'gene', 'monocytes', 'promonocytic']\n>>>\nExample14: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample15: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample16: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .\nAnswer:\n"
    },
    {
        "idx": 600,
        "sentence": "Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .",
        "label": {
            "immunoglobulin heavy-chain gene": "DNA",
            "lymphoid-specific enhancer element": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample2: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample3: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample4: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample5: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample6: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample7: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample8: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample9: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample10: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample11: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample12: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample13: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample14: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample15: Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\nTRFs set: ['kinase', 'tyrosine', 'lymphocytes', 'thymocytes', 'gene']\n>>>\nExample16: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .\nAnswer:\n"
    },
    {
        "idx": 1698,
        "sentence": "Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .",
        "label": {
            "natural killer cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample2: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample3: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample4: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample7: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample8: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample9: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample10: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample11: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample12: Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal , calphostin C , and ceramide .\nTRFs set: ['clones', 'promonocytic', 'kinase', 'cells', 'cell']\n>>>\nExample13: Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'genes', 'cells']\n>>>\nExample14: To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils .\nTRFs set: ['neutrophils', 'macrophages', 'kinase', 'monocytes', 'NF']\n>>>\nExample15: These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'lymphocytes']\n>>>\nExample16: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .\nAnswer:\n"
    },
    {
        "idx": 1287,
        "sentence": "Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .",
        "label": {
            "Platelet thromboxane receptors": "protein",
            "Platelet": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample2: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample3: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample4: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample5: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample6: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample7: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample8: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample9: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample10: Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes .\nTRFs set: ['monocytes', 'macrophages', 'kinase', 'blood', 'cells']\n>>>\nExample11: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample12: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample13: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample14: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample15: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample16: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .\nAnswer:\n"
    },
    {
        "idx": 1266,
        "sentence": "Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .",
        "label": {
            "EBV -positive B cell lines": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample2: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample3: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample4: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample5: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample6: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample7: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample8: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample9: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample10: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample11: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample12: Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'cells', 'leukocytes']\n>>>\nExample13: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample14: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample15: Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\nTRFs set: ['HeLa', 'cells', 'gene', 'genes', 'cell']\n>>>\nExample16: Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'genes', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .\nAnswer:\n"
    },
    {
        "idx": 1813,
        "sentence": "Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .",
        "label": {
            "BLR2 mRNA": "RNA",
            "BLR2": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample2: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample3: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample4: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample7: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample8: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample9: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample10: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample11: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample12: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample13: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample14: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample15: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .\nAnswer:\n"
    },
    {
        "idx": 1764,
        "sentence": "The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .",
        "label": {
            "AP-1": "protein",
            "NF-kappa B": "protein",
            "transcription factor": "protein",
            "mitogen-stimulated cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample2: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample5: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample6: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample7: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample8: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample9: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample10: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample11: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample12: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample13: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample14: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample15: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample16: While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\nTRFs set: ['kinase', 'promoter', 'phosphorylation', 'activation', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .\nAnswer:\n"
    },
    {
        "idx": 740,
        "sentence": "On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.",
        "label": {
            "ubiquitous Oct-1": "protein",
            "Oct-1": "protein",
            "Oct-2A": "protein",
            "lymphoid-specific Oct-2A": "protein",
            "N-Oct-factors": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample2: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample5: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample6: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample7: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample8: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample9: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample10: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample11: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample12: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample13: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample14: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample15: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample16: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.\nAnswer:\n"
    },
    {
        "idx": 1182,
        "sentence": "Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .",
        "label": {
            "IL-2": "protein",
            "T cells": "cell_type",
            "COOH-terminal region": "protein",
            "human T cells": "cell_type",
            "Ser386-Val525": "protein",
            "JAK3": "protein",
            "STAT transcription factor": "protein",
            "STAT5": "protein",
            "IL-2R beta": "protein",
            "IL-2R gamma": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample2: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample3: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample4: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample7: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample8: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample9: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample13: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample14: Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\nTRFs set: ['kinase', 'phosphorylation', 'neutrophils', 'promonocytic', 'enhancer']\n>>>\nExample15: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample16: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .\nAnswer:\n"
    },
    {
        "idx": 393,
        "sentence": "We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.",
        "label": {
            "HNP-1": "protein",
            "pag": "DNA",
            "NP-1": "protein",
            "defensins": "protein",
            "NP-5": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample2: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample3: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample4: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample5: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample8: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample9: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample10: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample11: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample12: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample13: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample14: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample15: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample16: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.\nAnswer:\n"
    },
    {
        "idx": 1442,
        "sentence": "T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .",
        "label": {
            "interleukin 3": "protein",
            "transcriptional start site": "DNA",
            "IL-3": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample2: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample3: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample4: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample10: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample11: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample12: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample13: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample14: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample15: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample16: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .\nAnswer:\n"
    },
    {
        "idx": 142,
        "sentence": "This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .",
        "label": {
            "U937 cells": "cell_line",
            "NF-kappa B": "protein",
            "viral RNA": "RNA",
            "TNF-alpha": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample2: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample3: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample4: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample5: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample6: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample7: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample8: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample9: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample10: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample11: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample12: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample13: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample14: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample15: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample16: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .\nAnswer:\n"
    },
    {
        "idx": 93,
        "sentence": "The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .",
        "label": {
            "canonical TATA box": "DNA",
            "\"housekeeping\" promoter": "DNA",
            "methylation-free island": "DNA",
            "5'-end termini": "RNA",
            "Thy-1 gene promoter": "DNA",
            "mRNA": "RNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample2: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample3: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample4: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample5: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample6: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample9: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample12: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample13: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample14: While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\nTRFs set: ['kinase', 'promoter', 'phosphorylation', 'activation', 'enhancer']\n>>>\nExample15: This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cell', 'thymocytes']\n>>>\nExample16: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .\nAnswer:\n"
    },
    {
        "idx": 1354,
        "sentence": "In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .",
        "label": {
            "TCF-1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample2: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample3: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample4: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample5: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample6: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample7: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample8: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample9: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample10: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample13: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample14: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample15: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample16: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .\nAnswer:\n"
    },
    {
        "idx": 466,
        "sentence": "(ABSTRACT TRUNCATED AT 250 WORDS)",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : '(ABSTRACT TRUNCATED AT 250 WORDS)'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample2: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample3: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample4: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample5: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample6: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample7: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample8: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample9: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample10: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample13: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample14: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample15: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : '(ABSTRACT TRUNCATED AT 250 WORDS)'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: (ABSTRACT TRUNCATED AT 250 WORDS)\nAnswer:\n"
    },
    {
        "idx": 1583,
        "sentence": "Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.",
        "label": {
            "ribonucleoproteins": "protein",
            "Ro(SSA)": "protein",
            "autoantibodies": "protein",
            "HLA class II antigens": "protein",
            "La(SSB)": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample2: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample3: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample4: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample5: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample6: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample9: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample10: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample11: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample12: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample13: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample14: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample15: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample16: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.\nAnswer:\n"
    },
    {
        "idx": 592,
        "sentence": "The DNA isolated contained an open reading frame encoding 108 amino acid residues .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample2: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample3: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample4: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample5: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample6: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample7: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample8: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample9: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample10: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample11: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample12: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample13: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample14: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample15: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n>>>\nExample16: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The DNA isolated contained an open reading frame encoding 108 amino acid residues .\nAnswer:\n"
    },
    {
        "idx": 163,
        "sentence": "This phenomenon can be mimicked by administering MP in divided doses.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This phenomenon can be mimicked by administering MP in divided doses.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample2: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample3: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample4: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample5: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample6: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample9: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample10: When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\nTRFs set: ['thymocytes', 'monocytes', 'lymphocytes', 'macrophages', 'THP']\n>>>\nExample11: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample12: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample13: Expression of Tip and Tap in Jurkat-T cells induced dramatic cell aggregation.\nTRFs set: ['cells', 'thymocytes', 'cell', 'kinase', 'Jurkat']\n>>>\nExample14: MATERIALS AND METHODS: Human monocytes were stimulated with PMA (50 ng/ml) alone or LPS (100 ng/ml) with and without a nonspecific serine /threonine protein kinase inhibitor staurosporine (Stauro), a specific pan- PKC inhibitor bisindolylmaleimide ( Bis ), or an inhibitor of PTK genistein ( Gen ).\nTRFs set: ['monocytes', 'kinase', 'promonocytic', 'phosphorylation', 'macrophages']\n>>>\nExample15: We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'kappa', 'RNAs']\n>>>\nExample16: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This phenomenon can be mimicked by administering MP in divided doses.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This phenomenon can be mimicked by administering MP in divided doses.\nAnswer:\n"
    },
    {
        "idx": 1751,
        "sentence": "This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.",
        "label": {
            "NFAT": "protein",
            "calcineurin": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample2: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample3: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample4: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample5: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample6: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample7: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample8: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample9: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample10: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample11: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample12: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample13: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample14: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample15: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample16: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.\nAnswer:\n"
    },
    {
        "idx": 1774,
        "sentence": "Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .",
        "label": {
            "PBMC": "cell_type",
            "PBMC receptors": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample2: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample3: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample4: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample5: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample6: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample7: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample8: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample9: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample10: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample11: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample12: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample13: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample14: These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'mRNA', 'lymphocytes']\n>>>\nExample15: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n>>>\nExample16: A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction , but also abolishes most of the VitD3 induction of CD14 expression .\nTRFs set: ['promoter', 'THP', 'kinase', 'phosphorylation', 'mRNA']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .\nAnswer:\n"
    },
    {
        "idx": 206,
        "sentence": "It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .",
        "label": {
            "ER": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample2: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample3: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample4: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample7: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample8: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample9: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample10: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n>>>\nExample11: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample12: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample13: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample14: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample15: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample16: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .\nAnswer:\n"
    },
    {
        "idx": 928,
        "sentence": "A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).",
        "label": {
            "ets-1": "protein",
            "long terminal repeat": "DNA",
            "double-stranded oligonucleotide probe": "DNA",
            "mouse thymus cDNA expression library": "DNA",
            "mouse ets-1 cDNA clone": "DNA",
            "LTR": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample2: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample3: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample4: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample7: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample8: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample9: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample10: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample11: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample12: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample13: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample14: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample15: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample16: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).\nAnswer:\n"
    },
    {
        "idx": 1301,
        "sentence": "It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .",
        "label": {
            "ER": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\nTRFs set: ['kinase', 'phosphorylation', 'neutrophils', 'promonocytic', 'enhancer']\n>>>\nExample2: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample3: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample4: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample5: The expression of NDP kinase was intense in KA and SCC compared with BCC .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'kappa', 'cells']\n>>>\nExample6: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample9: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample10: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample11: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample12: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample13: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample14: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample15: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample16: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .\nAnswer:\n"
    },
    {
        "idx": 1708,
        "sentence": "The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .",
        "label": {
            "nuclear factor (NF)-kappa B": "protein",
            "T cell lines": "cell_line",
            "Ca(2+) -dependent phosphatase": "protein",
            "PKC": "protein",
            "calcineurin": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample2: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample3: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample4: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample5: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample6: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample7: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample8: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample9: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample10: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample11: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample12: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample13: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample14: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample15: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample16: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .\nAnswer:\n"
    },
    {
        "idx": 747,
        "sentence": "Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).",
        "label": {
            "unspliced mRNA": "RNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample4: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample5: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample6: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample7: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample8: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample9: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample10: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample11: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample12: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample13: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample14: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample15: Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\nTRFs set: ['kinase', 'tyrosine', 'lymphocytes', 'thymocytes', 'gene']\n>>>\nExample16: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).\nAnswer:\n"
    },
    {
        "idx": 333,
        "sentence": "These protoenhancers alone are weakly or not responsive to R .",
        "label": {
            "protoenhancers": "DNA",
            "R": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These protoenhancers alone are weakly or not responsive to R .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample2: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample3: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample6: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample7: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample10: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample11: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample12: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample13: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample14: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample15: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample16: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These protoenhancers alone are weakly or not responsive to R .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: These protoenhancers alone are weakly or not responsive to R .\nAnswer:\n"
    },
    {
        "idx": 758,
        "sentence": "Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.",
        "label": {
            "CEM-C7": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample2: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample3: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample4: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample5: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample6: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample7: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample8: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample9: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample10: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample11: Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\nTRFs set: ['blood', 'cells', 'gene', 'monocytes', 'promonocytic']\n>>>\nExample12: Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal , calphostin C , and ceramide .\nTRFs set: ['clones', 'promonocytic', 'kinase', 'cells', 'cell']\n>>>\nExample13: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample14: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n>>>\nExample15: We isolated a novel subline, UT-7/GMT , from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).\nTRFs set: ['gene', 'blood', 'cells', 'leukocytes', 'cell']\n>>>\nExample16: The modified vectors were used to transduce human hematopoietic cell lines , cord blood-derived CD34(+) stem/progenitor cells , and murine bone marrow repopulating stem cells .\nTRFs set: ['thymocytes', 'promonocytic', 'cells', 'monocytes', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.\nAnswer:\n"
    },
    {
        "idx": 727,
        "sentence": "The importance of the internal ATGs to Rex function is not known.",
        "label": {
            "Rex": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The importance of the internal ATGs to Rex function is not known.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: These two related genes share the evolutionarily conserved region encoding the Runt domain .\nTRFs set: ['genes', 'gene', 'kinase', 'RNAs', 'mRNA']\n>>>\nExample2: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample3: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample4: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample5: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample6: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample7: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample8: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample9: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample13: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample14: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample15: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample16: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The importance of the internal ATGs to Rex function is not known.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The importance of the internal ATGs to Rex function is not known.\nAnswer:\n"
    },
    {
        "idx": 429,
        "sentence": "As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.",
        "label": {
            "TSAP": "protein",
            "mammalian protein": "protein",
            "sea urchin binding sites": "DNA",
            "BSAP": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample2: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample3: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample4: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample5: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample6: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample7: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample8: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample9: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample10: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample11: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample12: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample13: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample14: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample15: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample16: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.\nAnswer:\n"
    },
    {
        "idx": 1372,
        "sentence": "The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).",
        "label": {
            "14q32.1": "DNA",
            "TCR alpha/beta loci": "DNA",
            "t(14;14)(q11;q32.1)": "DNA",
            "TCL1 oncogene": "DNA",
            "human chromosome": "DNA",
            "t(7;14)(q35;q32.1)": "DNA",
            "inv14(q11;q32.1)": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .\nTRFs set: ['gene', 'enhancer', 'genes', 'mRNA', 'promoter']\n>>>\nExample2: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample3: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample4: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample7: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample8: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample9: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample10: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample11: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample12: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample13: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample14: By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\nTRFs set: ['clones', 'gene', 'genes', 'cells', 'phosphorylation']\n>>>\nExample15: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample16: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).\nAnswer:\n"
    },
    {
        "idx": 546,
        "sentence": "Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .",
        "label": {
            "T lymphocytes": "cell_type",
            "immunophilin": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample2: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample3: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample4: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample5: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample6: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample7: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample8: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample9: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample10: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample11: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample12: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample13: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample14: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample15: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample16: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .\nAnswer:\n"
    },
    {
        "idx": 1437,
        "sentence": "In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.",
        "label": {
            "hTR beta 1": "protein",
            "hTR beta 1 mRNA": "RNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample3: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample4: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample5: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample6: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample9: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample10: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample11: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample12: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample13: Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\nTRFs set: ['blood', 'cells', 'gene', 'monocytes', 'promonocytic']\n>>>\nExample14: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample15: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample16: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.\nAnswer:\n"
    },
    {
        "idx": 1399,
        "sentence": "To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .",
        "label": {
            "hematopoietic cell lineage": "cell_line",
            "human estrogen receptor": "protein",
            "NF-M": "protein",
            "hormone binding domain": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample2: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample3: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample4: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample5: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample6: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample7: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample8: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample9: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample10: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample11: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample12: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample13: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample14: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample15: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample16: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .\nAnswer:\n"
    },
    {
        "idx": 1327,
        "sentence": "Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .",
        "label": {
            "human IL-4": "protein",
            "human IL-4 promoter": "DNA",
            "NF-IL6": "protein",
            "T cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample2: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample3: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample4: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample5: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample6: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample7: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample8: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample9: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample10: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample11: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample12: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample13: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample16: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .\nAnswer:\n"
    },
    {
        "idx": 146,
        "sentence": "Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .",
        "label": {
            "\"octamer\" motif": "DNA",
            "HLA-DR alpha (DRA) promoter": "DNA",
            "class II promoters": "DNA",
            "immunoglobulin variable region promoters": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample2: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample3: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample4: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample5: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample8: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample9: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample10: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample11: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample12: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample13: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample14: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample15: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample16: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .\nAnswer:\n"
    },
    {
        "idx": 1247,
        "sentence": "The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .",
        "label": {
            "Janus family tyrosine kinase": "protein",
            "Jak3": "protein",
            "gamma c": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample2: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample3: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample4: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample5: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample6: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample7: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample8: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample9: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample10: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample11: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample12: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample13: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample14: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample15: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample16: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .\nAnswer:\n"
    },
    {
        "idx": 1300,
        "sentence": "As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample2: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample3: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample4: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample5: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample6: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample7: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample8: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample9: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample10: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample11: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample12: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample13: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample14: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample15: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample16: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .\nAnswer:\n"
    },
    {
        "idx": 350,
        "sentence": "Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .",
        "label": {
            "control cell line": "cell_line",
            "cell line": "cell_line",
            "Ro-VDR": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample2: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample5: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample6: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample7: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample8: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample9: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample10: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample11: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample12: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample13: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample14: Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'cells', 'blood']\n>>>\nExample15: Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\nTRFs set: ['blood', 'cells', 'gene', 'monocytes', 'promonocytic']\n>>>\nExample16: Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'cells', 'leukocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .\nAnswer:\n"
    },
    {
        "idx": 1093,
        "sentence": "The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).",
        "label": {
            "VDR": "protein",
            "vitamin D receptor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample2: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample3: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample4: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample5: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample6: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample7: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample8: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample9: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample10: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample11: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample12: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample13: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample14: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample15: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample16: Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'cells', 'blood']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).\nAnswer:\n"
    },
    {
        "idx": 1493,
        "sentence": "Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .",
        "label": {
            "myeloid cells": "cell_type",
            "NF-kappa B": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample2: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample3: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample4: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample5: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample6: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample7: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample10: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample11: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample12: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample13: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample14: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample15: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample16: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .\nAnswer:\n"
    },
    {
        "idx": 334,
        "sentence": "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .",
        "label": {
            "protoenhancers": "DNA",
            "overlapping palindromes": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample2: Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .\nTRFs set: ['gene', 'enhancer', 'genes', 'mRNA', 'promoter']\n>>>\nExample3: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample4: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample5: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample8: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample9: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample10: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample11: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample12: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample13: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample16: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .\nAnswer:\n"
    },
    {
        "idx": 946,
        "sentence": "Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample2: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample3: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample4: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample5: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample6: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample9: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample10: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample11: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample12: The expression of NDP kinase was intense in KA and SCC compared with BCC .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'kappa', 'cells']\n>>>\nExample13: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample14: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample15: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample16: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .\nAnswer:\n"
    },
    {
        "idx": 777,
        "sentence": "We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.",
        "label": {
            "OTF-2": "protein",
            "immunoglobulin gene": "DNA",
            "steady-state immunoglobulin heavy-chain mRNA": "RNA",
            "human pre-B-cell lines": "cell_line",
            "immunoglobulin heavy-chain": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample2: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample3: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample4: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample7: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample8: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample9: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample12: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample13: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample14: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample15: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample16: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.\nAnswer:\n"
    },
    {
        "idx": 552,
        "sentence": "Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .",
        "label": {
            "IL-2": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample2: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample3: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample4: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample5: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample6: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample7: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample8: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample9: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample10: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample13: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample14: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample15: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample16: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .\nAnswer:\n"
    },
    {
        "idx": 1310,
        "sentence": "The abundant chromosomal protein HMG-1 belongs to this subgroup.",
        "label": {
            "HMG-1": "protein",
            "chromosomal protein": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The abundant chromosomal protein HMG-1 belongs to this subgroup.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample2: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample3: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample4: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n>>>\nExample5: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample6: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample7: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample10: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample11: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample12: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample13: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample14: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample15: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample16: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The abundant chromosomal protein HMG-1 belongs to this subgroup.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The abundant chromosomal protein HMG-1 belongs to this subgroup.\nAnswer:\n"
    },
    {
        "idx": 1409,
        "sentence": "We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .",
        "label": {
            "IL-2": "protein",
            "T cell lines": "cell_line",
            "PRL": "protein",
            "Stat proteins": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample2: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample3: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample4: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample5: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample6: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample7: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample10: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample11: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample12: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample13: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample14: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample15: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample16: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .\nAnswer:\n"
    },
    {
        "idx": 1140,
        "sentence": "The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .",
        "label": {
            "transcription factors": "protein",
            "conserved cis-acting sequence": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample2: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample5: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample8: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample9: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample10: Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\nTRFs set: ['promoter', 'activation', 'mRNA', 'kinase', 'genes']\n>>>\nExample11: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample12: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample13: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample14: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample15: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample16: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .\nAnswer:\n"
    },
    {
        "idx": 449,
        "sentence": "We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .",
        "label": {
            "ubiquitous transcription factor": "protein",
            "E3 enhancer motif": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample2: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample3: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample4: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample5: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample6: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample7: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample8: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample9: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample10: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample11: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample12: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample13: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample14: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample15: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample16: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .\nAnswer:\n"
    },
    {
        "idx": 1402,
        "sentence": "At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .",
        "label": {
            "eosinophil": "cell_type",
            "myeloid lineages": "cell_type",
            "differentiation markers": "protein",
            "progenitor-specific surface markers": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample2: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample3: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample4: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample5: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample6: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample7: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample8: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample9: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample10: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample11: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample12: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample13: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample14: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample15: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample16: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .\nAnswer:\n"
    },
    {
        "idx": 664,
        "sentence": "Interferon-gamma and the sexual dimorphism of autoimmunity .",
        "label": {
            "Interferon-gamma": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Interferon-gamma and the sexual dimorphism of autoimmunity .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample2: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample3: In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'endobronchial', 'gene']\n>>>\nExample4: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample5: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample6: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample7: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample8: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample9: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample12: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample13: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample16: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Interferon-gamma and the sexual dimorphism of autoimmunity .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Interferon-gamma and the sexual dimorphism of autoimmunity .\nAnswer:\n"
    },
    {
        "idx": 1726,
        "sentence": "It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .",
        "label": {
            "NF-kappa B": "protein",
            "cytotoxic cytokine": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample2: Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\nTRFs set: ['kinase', 'neutrophils', 'activation', 'NF', 'macrophages']\n>>>\nExample3: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample4: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample5: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample6: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample7: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample8: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample9: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample10: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample11: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample12: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample13: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample14: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample15: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample16: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .\nAnswer:\n"
    },
    {
        "idx": 1573,
        "sentence": "Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .",
        "label": {
            "estrogen": "protein",
            "eosinophil cationic protein": "protein",
            "positive cells": "cell_type",
            "progesterone receptors": "protein",
            "eosinophils": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample2: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample3: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample4: Eosinophils play an important role in the effector phase of allergic inflammation .\nTRFs set: ['lymphocytes', 'neutrophils', 'leukocytes', 'macrophages', 'monocytes']\n>>>\nExample5: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample6: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample7: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample10: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample11: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample12: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample13: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample14: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample15: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample16: To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs , and identified a negative element from bp -267 to -246 of the gp91phox gene , the deletion of which caused an 83% increase in promoter activity .\nTRFs set: ['promoter', 'gene', 'enhancer', 'kinase', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .\nAnswer:\n"
    },
    {
        "idx": 1589,
        "sentence": "Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .",
        "label": {
            "NF-kappa B": "protein",
            "T helper cell subsets": "cell_type",
            "NF-AT": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample2: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample3: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample4: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample5: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample6: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample9: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample10: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample11: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample12: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample13: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample16: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .\nAnswer:\n"
    },
    {
        "idx": 114,
        "sentence": "These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .",
        "label": {
            "NF-KB": "protein",
            "monocytic cell lineage": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample2: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample3: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample4: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample7: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample8: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample9: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample10: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample11: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample12: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample13: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample14: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample15: These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'mRNA', 'lymphocytes']\n>>>\nExample16: Mononuclear phagocytes are exposed to fibrinous provisional matrix throughout migration into inflammatory foci, so this study was undertaken to determine whether fibrinogen triggers activation of NF-kappa B transcription factors .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'neutrophils']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .\nAnswer:\n"
    },
    {
        "idx": 469,
        "sentence": "Cardiac and adrenergic diseases were excluded.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cardiac and adrenergic diseases were excluded.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample2: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample3: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample4: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample5: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample6: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample7: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample8: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample9: In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.\nTRFs set: ['promonocytic', 'lymphocytes', 'monocytes', 'macrophages', 'mRNA']\n>>>\nExample10: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample11: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample12: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample13: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample14: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n>>>\nExample15: Recently, it has been shown that RelB knockout mice have no dendritic cells ( DC ).\nTRFs set: ['thymocytes', 'lymphocytes', 'monocytes', 'cells', 'cell']\n>>>\nExample16: Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\nTRFs set: ['lymphocytes', 'promoter', 'promonocytic', 'thymocytes', 'mRNA']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cardiac and adrenergic diseases were excluded.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Cardiac and adrenergic diseases were excluded.\nAnswer:\n"
    },
    {
        "idx": 1683,
        "sentence": "These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .",
        "label": {
            "c-jun": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample2: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample3: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample4: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample5: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample6: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample7: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample8: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample9: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample10: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample11: Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'cells', 'blood']\n>>>\nExample12: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample13: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample14: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample15: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample16: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .\nAnswer:\n"
    },
    {
        "idx": 1648,
        "sentence": "Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.",
        "label": {
            "PU.1 site": "DNA",
            "GM-CSF receptor alpha": "protein",
            "GM-CSF receptor alpha promoter": "DNA",
            "myelomonocytic cells": "cell_type",
            "C/EBP": "protein",
            "PU.1": "protein",
            "GM-CSF": "protein",
            "C/EBP site": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample2: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample3: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample6: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample7: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample10: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample11: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample12: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample13: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample14: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample15: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample16: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.\nAnswer:\n"
    },
    {
        "idx": 646,
        "sentence": "Surgically confirmed nodal involvement was observed in 42%.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Surgically confirmed nodal involvement was observed in 42%.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample2: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample3: The expression of NDP kinase was intense in KA and SCC compared with BCC .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'kappa', 'cells']\n>>>\nExample4: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample5: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample6: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample7: By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\nTRFs set: ['clones', 'gene', 'genes', 'cells', 'phosphorylation']\n>>>\nExample8: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample9: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample10: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample11: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample12: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample13: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample14: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample15: Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population , while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\nTRFs set: ['promonocytic', 'monocytes', 'kinase', 'lymphocytes', 'thymocytes']\n>>>\nExample16: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Surgically confirmed nodal involvement was observed in 42%.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Surgically confirmed nodal involvement was observed in 42%.\nAnswer:\n"
    },
    {
        "idx": 821,
        "sentence": "(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .",
        "label": {
            "LMP1": "protein",
            "EBNA-2": "protein",
            "EBV type 1 EBNA-2": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample2: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample3: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample4: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample5: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample6: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample7: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample8: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample11: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample12: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample13: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample14: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample15: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample16: ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\nTRFs set: ['lymphocytes', 'promonocytic', 'monocytes', 'thymocytes', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: (vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .\nAnswer:\n"
    },
    {
        "idx": 548,
        "sentence": "On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample3: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample4: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample5: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample6: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample7: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample8: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample9: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample10: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample11: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample12: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample13: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample14: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample15: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample16: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .\nAnswer:\n"
    },
    {
        "idx": 135,
        "sentence": "Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).",
        "label": {
            "U9-IIIB": "cell_line",
            "monocytic U937 cells": "cell_line",
            "Tumor necrosis factor alpha ( TNF-alpha ) mRNA": "RNA",
            "chronically HIV infected U937 cell line": "cell_line",
            "Tumor necrosis factor alpha": "protein",
            "TNF-alpha": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\nTRFs set: ['thymocytes', 'monocytes', 'lymphocytes', 'macrophages', 'THP']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample4: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample7: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample8: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample9: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample10: Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .\nTRFs set: ['kinase', 'lymphocytes', 'enhancer', 'promonocytic', 'thymocytes']\n>>>\nExample11: Regulation and specificity of MNDA expression in monocytes , macrophages , and leukemia/B lymphoma cell lines .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'lymphocytes', 'leukocytes']\n>>>\nExample12: Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'lymphocytes', 'gene']\n>>>\nExample13: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample14: Mononuclear phagocytes are exposed to fibrinous provisional matrix throughout migration into inflammatory foci, so this study was undertaken to determine whether fibrinogen triggers activation of NF-kappa B transcription factors .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample15: These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'lymphocytes']\n>>>\nExample16: We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'promoter', 'tyrosine']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).\nAnswer:\n"
    },
    {
        "idx": 432,
        "sentence": "Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .",
        "label": {
            "transfected B cells": "cell_line",
            "TSAP": "protein",
            "mutant TSAP -binding site": "DNA",
            "upstream promoter element": "DNA",
            "BSAP": "protein",
            "B-cell-specific transcription factor": "protein",
            "wild-type": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample2: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample3: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample4: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample5: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample6: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample9: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample10: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample11: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample12: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample13: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample14: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample15: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample16: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .\nAnswer:\n"
    },
    {
        "idx": 1161,
        "sentence": "Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .",
        "label": {
            "I kappa B alpha": "protein",
            "NF kappa B": "protein",
            "NF kappa B -I kappa B complex": "protein",
            "TNF-alpha": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample2: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample3: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample4: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample5: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample6: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample7: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample8: When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\nTRFs set: ['thymocytes', 'monocytes', 'lymphocytes', 'macrophages', 'THP']\n>>>\nExample9: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample10: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample11: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample12: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample13: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample14: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample15: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample16: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .\nAnswer:\n"
    },
    {
        "idx": 1794,
        "sentence": "Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .",
        "label": {
            "STAT": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample2: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample3: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample4: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample5: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample6: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample7: Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\nTRFs set: ['promoter', 'activation', 'mRNA', 'kinase', 'genes']\n>>>\nExample8: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample9: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample10: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample11: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample12: Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\nTRFs set: ['kinase', 'phosphorylation', 'neutrophils', 'promonocytic', 'enhancer']\n>>>\nExample13: Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\nTRFs set: ['kinase', 'lymphocytes', 'promonocytic', 'promoter', 'thymocytes']\n>>>\nExample14: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample15: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample16: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .\nAnswer:\n"
    },
    {
        "idx": 1470,
        "sentence": "Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .",
        "label": {
            "neutrophil": "cell_type",
            "tumor necrosis factor (TNF)-alpha": "protein",
            "leukocyte adhesion molecule": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample2: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample3: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample4: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample5: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample6: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample7: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample8: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample9: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample10: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample11: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample12: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample13: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample14: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample15: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .\nAnswer:\n"
    },
    {
        "idx": 644,
        "sentence": "Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?",
        "label": {
            "tumor cells": "cell_type",
            "hematopoietic growth factor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample2: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample3: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample4: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample5: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample6: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample7: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample8: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample9: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample10: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample11: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample12: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample13: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample14: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample15: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?\nAnswer:\n"
    },
    {
        "idx": 435,
        "sentence": "Antibodies are produced exclusively in B lymphocytes .",
        "label": {
            "Antibodies": "protein",
            "lymphocytes": "cell_type",
            "B lymphocytes": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Antibodies are produced exclusively in B lymphocytes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample2: Eosinophils play an important role in the effector phase of allergic inflammation .\nTRFs set: ['lymphocytes', 'neutrophils', 'leukocytes', 'macrophages', 'monocytes']\n>>>\nExample3: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample4: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample5: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample6: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample7: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample8: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample9: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample10: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample11: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample12: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample13: Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\nTRFs set: ['lymphocytes', 'leukocytes', 'tyrosine', 'thymocytes', 'blood']\n>>>\nExample14: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample15: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample16: ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\nTRFs set: ['lymphocytes', 'promonocytic', 'monocytes', 'thymocytes', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Antibodies are produced exclusively in B lymphocytes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Antibodies are produced exclusively in B lymphocytes .\nAnswer:\n"
    },
    {
        "idx": 1342,
        "sentence": "While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.",
        "label": {
            "amino acid domain": "protein",
            "BH1": "protein",
            "BH3": "protein",
            "Bak": "protein",
            "BH2": "protein",
            "Bax": "protein",
            "Bik": "protein",
            "Bcl-2 family": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample2: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample3: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample4: These two related genes share the evolutionarily conserved region encoding the Runt domain .\nTRFs set: ['genes', 'gene', 'kinase', 'RNAs', 'mRNA']\n>>>\nExample5: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample6: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample7: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample8: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample11: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample12: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample13: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample14: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample15: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample16: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.\nAnswer:\n"
    },
    {
        "idx": 1022,
        "sentence": "NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .",
        "label": {
            "NK cell NFAT": "protein",
            "AP-1": "protein",
            "nonstimulated cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample2: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample3: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample4: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample5: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample6: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample9: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample10: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample11: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample12: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample13: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample14: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample15: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .\nAnswer:\n"
    },
    {
        "idx": 810,
        "sentence": "Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .",
        "label": {
            "CML cells": "cell_type",
            "IFN-alpha": "protein",
            "CML cytoplasmic proteins": "protein",
            "nuclear protein-DNA complexes": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample2: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample5: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample6: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample7: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample8: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample9: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample10: When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\nTRFs set: ['thymocytes', 'monocytes', 'lymphocytes', 'macrophages', 'THP']\n>>>\nExample11: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample12: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample13: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample14: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample15: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample16: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .\nAnswer:\n"
    },
    {
        "idx": 1811,
        "sentence": "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .",
        "label": {
            "BLR1": "protein",
            "BLR2": "protein",
            "seven transmembrane receptor": "protein",
            "activated lymphocytes": "cell_type",
            "chemokine receptors": "protein",
            "Burkitt's lymphoma receptor 1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample2: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample7: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample8: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample9: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample10: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample11: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample12: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample13: This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .\nTRFs set: ['kinase', 'monocytes', 'promonocytic', 'mRNA', 'macrophages']\n>>>\nExample14: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample15: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample16: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .\nAnswer:\n"
    },
    {
        "idx": 1316,
        "sentence": "Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.",
        "label": {
            "Helix III": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample2: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample5: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample6: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample7: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample8: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample9: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample10: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample11: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample12: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample13: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample14: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample15: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample16: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.\nAnswer:\n"
    },
    {
        "idx": 939,
        "sentence": "However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.",
        "label": {
            "type II EBS": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample2: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample3: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample4: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample5: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample6: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample7: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample8: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample9: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample10: Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo -induced beta-globin expression , leading to a marked increase in haemoglobin production .\nTRFs set: ['enhancer', 'HeLa', 'promoter', 'mRNA', 'blood']\n>>>\nExample11: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample12: Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1 .\nTRFs set: ['phosphorylation', 'promoter', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample13: Despite this drastic effect in vivo, the in vitro immortalization of erythropoietin-dependent erythroid progenitors unexpectedly occurred at low frequency, and all four cell lines established expressed both erythrocytic (globins) and megakaryocytic markers ( glycoprotein IIb , platelet factor 4 ) as well as Spi-1 and Fli-1 transcripts at permissive temperature .\nTRFs set: ['promonocytic', 'monocytes', 'blood', 'kinase', 'lymphocytes']\n>>>\nExample14: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n>>>\nExample15: A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1 , FVC , and peak expiratory flow ( PEF ) after oral prednisolone .\nTRFs set: ['endobronchial', 'patients', 'cryptococcal', 'FP', 'peripheral']\n>>>\nExample16: The predominant E2F complex in human primary haemopoietic cells and in AML blasts contains E2F-4 , DP-1 and p130 .\nTRFs set: ['promonocytic', 'kinase', 'lymphocytes', 'cells', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.\nAnswer:\n"
    },
    {
        "idx": 292,
        "sentence": "We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.",
        "label": {
            "globin gene": "DNA",
            "mouse embryonic stem (ES) cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample2: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample3: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample4: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample5: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample6: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample7: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample8: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample9: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample10: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample11: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample12: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample13: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample14: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample15: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample16: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.\nAnswer:\n"
    },
    {
        "idx": 542,
        "sentence": "Amino acid sequences of all proteins are essays written in the same language.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Amino acid sequences of all proteins are essays written in the same language.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample2: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample3: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample4: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample5: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample6: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n>>>\nExample7: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample8: These two related genes share the evolutionarily conserved region encoding the Runt domain .\nTRFs set: ['genes', 'gene', 'kinase', 'RNAs', 'mRNA']\n>>>\nExample9: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample10: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample11: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample12: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample13: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample14: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample15: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample16: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Amino acid sequences of all proteins are essays written in the same language.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Amino acid sequences of all proteins are essays written in the same language.\nAnswer:\n"
    },
    {
        "idx": 505,
        "sentence": "The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .",
        "label": {
            "Jurkat": "cell_line",
            "TCF-1 alpha": "protein",
            "TCR": "protein",
            "T-cell-specific transcription factor": "protein",
            "TCF-1 alpha binding site": "DNA",
            "HeLa cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample2: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample5: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample6: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample7: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample8: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample9: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample10: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample11: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample12: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample13: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample14: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample15: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample16: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .\nAnswer:\n"
    },
    {
        "idx": 1525,
        "sentence": "Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .",
        "label": {
            "antibody": "protein",
            "CaM kinase II": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample2: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample3: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample4: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample5: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample6: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample7: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample8: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample9: The expression of NDP kinase was intense in KA and SCC compared with BCC .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'kappa', 'cells']\n>>>\nExample10: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample11: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample12: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample13: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample14: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample15: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample16: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .\nAnswer:\n"
    },
    {
        "idx": 1103,
        "sentence": "Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.",
        "label": {
            "platelets": "cell_type",
            "Rap1 protein": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample2: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample3: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample4: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample5: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample6: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample7: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample8: The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'RNAs']\n>>>\nExample9: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample10: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample11: Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\nTRFs set: ['kinase', 'phosphorylation', 'neutrophils', 'promonocytic', 'enhancer']\n>>>\nExample12: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample13: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample14: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample15: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample16: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.\nAnswer:\n"
    },
    {
        "idx": 538,
        "sentence": "Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .",
        "label": {
            "PHA": "protein",
            "phytohaemagglutinin": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample2: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample3: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample4: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample5: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample6: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample7: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample8: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample9: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample10: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample11: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample12: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample13: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample14: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample15: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample16: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .\nAnswer:\n"
    },
    {
        "idx": 1529,
        "sentence": "Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .",
        "label": {
            "Oct-2a": "protein",
            "lymphoid-specific transcription factor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample2: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample3: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample4: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample5: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample6: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample7: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample8: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample9: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample10: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample11: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample12: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample13: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample14: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample15: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample16: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .\nAnswer:\n"
    },
    {
        "idx": 1197,
        "sentence": "In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.",
        "label": {
            "ubiquitin": "protein",
            "p105 precursor": "protein",
            "E2-F1": "protein",
            "-proteasome": "protein",
            "ubiquitin -carrier protein": "protein",
            "p53": "protein",
            "ubiquitin -protein ligase": "protein",
            "320-kDa species": "protein",
            "p105": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample2: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample3: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample4: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample5: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample6: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample7: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample8: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample9: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample10: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample11: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample12: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample13: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample14: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample15: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample16: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.\nAnswer:\n"
    },
    {
        "idx": 877,
        "sentence": "Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .",
        "label": {
            "B lymphocytes": "cell_type",
            "thymic epithelial cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample2: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample3: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample4: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample5: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample8: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample9: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample10: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample11: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample12: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample13: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample14: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample15: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample16: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .\nAnswer:\n"
    },
    {
        "idx": 1838,
        "sentence": "First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.",
        "label": {
            "LEF-1 -binding site": "DNA",
            "HIV-1 enhancer": "DNA",
            "LEF-1": "protein",
            "GAL4-substituted HIV-1 enhancer": "DNA",
            "Jurkat T cells": "cell_line",
            "multimerized copies": "DNA",
            "LEF-1 /GAL4": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample5: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample6: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample7: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample8: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample9: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample10: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample11: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample12: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample13: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample14: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample15: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample16: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.\nAnswer:\n"
    },
    {
        "idx": 1195,
        "sentence": "Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .",
        "label": {
            "60-kDa precursor": "protein",
            "ubiquitin": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample2: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample3: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample4: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample5: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample6: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample7: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample8: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample9: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample10: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample11: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample12: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample13: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample14: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample15: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample16: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .\nAnswer:\n"
    },
    {
        "idx": 817,
        "sentence": "(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .",
        "label": {
            "EBNA-LP": "protein",
            "LMP1": "protein",
            "EBNA-2": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample2: Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'RNAs', 'cell']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample5: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample6: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample7: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample8: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample9: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample10: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample13: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample14: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample15: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample16: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: (ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .\nAnswer:\n"
    },
    {
        "idx": 741,
        "sentence": "In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .",
        "label": {
            "Oct-2A expression vector": "DNA",
            "Oct-2A": "protein",
            "N-Oct-3 factor": "protein",
            "melanoma cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample2: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample3: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample4: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample5: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample6: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample7: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample8: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample9: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample10: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample11: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample12: Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'RNAs', 'cell']\n>>>\nExample13: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample14: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample15: Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\nTRFs set: ['blood', 'cells', 'gene', 'monocytes', 'promonocytic']\n>>>\nExample16: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .\nAnswer:\n"
    },
    {
        "idx": 283,
        "sentence": "[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]",
        "label": {
            "Estrogen receptor": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample4: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample5: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample6: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample7: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample8: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample9: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample10: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample13: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample14: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample15: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample16: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: [ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]\nAnswer:\n"
    },
    {
        "idx": 1043,
        "sentence": "METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample2: Although erythropoietin ( Epo ) is essential for the production of mature red blood cells , the cooperation with other factors is required for a proper balance between progenitor proliferation and differentiation .\nTRFs set: ['blood', 'cells', 'promoter', 'tyrosine', 'lymphocytes']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample5: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample6: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample7: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample8: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample9: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample10: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample11: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample12: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample13: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample14: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample15: Despite this drastic effect in vivo, the in vitro immortalization of erythropoietin-dependent erythroid progenitors unexpectedly occurred at low frequency, and all four cell lines established expressed both erythrocytic (globins) and megakaryocytic markers ( glycoprotein IIb , platelet factor 4 ) as well as Spi-1 and Fli-1 transcripts at permissive temperature .\nTRFs set: ['promonocytic', 'monocytes', 'blood', 'kinase', 'lymphocytes']\n>>>\nExample16: Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development .\nTRFs set: ['promonocytic', 'cryptococcal', 'cells', 'monocytes', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .\nAnswer:\n"
    },
    {
        "idx": 1010,
        "sentence": "Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .",
        "label": {
            "murine NFATp": "protein",
            "NFATp protein": "protein",
            "NFATp": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample5: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample6: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample7: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample8: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample9: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample10: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample11: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample12: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample13: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample14: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample15: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample16: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .\nAnswer:\n"
    },
    {
        "idx": 186,
        "sentence": "We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .",
        "label": {
            "erythrocytic lineage": "cell_type",
            "NF-E2": "protein",
            "trans-acting factor": "protein",
            "megakaryocytes": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample2: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample3: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample4: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample5: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample6: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample7: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample8: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample9: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample10: Although erythropoietin ( Epo ) is essential for the production of mature red blood cells , the cooperation with other factors is required for a proper balance between progenitor proliferation and differentiation .\nTRFs set: ['blood', 'cells', 'promoter', 'tyrosine', 'lymphocytes']\n>>>\nExample11: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample12: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample13: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample14: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample15: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample16: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .\nAnswer:\n"
    },
    {
        "idx": 1547,
        "sentence": "Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .",
        "label": {
            "multisubunit adhesion receptor": "protein",
            "Ib-IX-V": "protein",
            "Platelet glycoprotein": "protein",
            "GP": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample2: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample3: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample4: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample5: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample6: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample7: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample8: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample9: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample10: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample11: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample12: The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'RNAs']\n>>>\nExample13: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample14: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample15: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample16: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .\nAnswer:\n"
    },
    {
        "idx": 96,
        "sentence": "We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .",
        "label": {
            "Sp1": "protein",
            "dominant promoter elements": "DNA",
            "minimal Thy-1 promoter": "DNA",
            "transcription factor": "protein",
            "multiple binding sites": "DNA",
            "CCAAT box": "DNA",
            "transcription start site": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample2: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample3: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample4: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample5: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample8: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample9: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample10: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample11: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample12: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample13: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample14: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample15: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample16: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .\nAnswer:\n"
    },
    {
        "idx": 1763,
        "sentence": "Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .",
        "label": {
            "IL-2": "protein",
            "IL-2 mRNA": "RNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample2: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample5: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample6: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample7: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample8: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample9: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample10: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample11: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample12: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample13: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample14: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample15: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample16: Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\nTRFs set: ['kinase', 'tyrosine', 'lymphocytes', 'thymocytes', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .\nAnswer:\n"
    },
    {
        "idx": 224,
        "sentence": "Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).",
        "label": {
            "CEM C7 cells": "cell_line",
            "human acute lymphoblastic T-cell line": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample2: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample3: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample4: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample5: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample6: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample7: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample8: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample9: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample10: Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\nTRFs set: ['lymphocytes', 'leukocytes', 'tyrosine', 'thymocytes', 'blood']\n>>>\nExample11: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample12: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample13: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample14: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample15: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample16: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).\nAnswer:\n"
    },
    {
        "idx": 313,
        "sentence": "Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .",
        "label": {
            "malignant soft tissue tumors": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample2: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample3: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample4: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample5: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample6: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample7: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample8: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample9: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample10: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample11: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample12: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample13: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample14: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample15: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample16: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .\nAnswer:\n"
    },
    {
        "idx": 1285,
        "sentence": "Characterization of 5' end of human thromboxane receptor gene .",
        "label": {
            "5' end of human thromboxane receptor gene": "DNA",
            "human thromboxane receptor gene": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Characterization of 5' end of human thromboxane receptor gene .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample2: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample5: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample6: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample7: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample8: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample9: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample10: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample11: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample12: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample13: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample14: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample15: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Characterization of 5' end of human thromboxane receptor gene .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Characterization of 5' end of human thromboxane receptor gene .\nAnswer:\n"
    },
    {
        "idx": 327,
        "sentence": "However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .",
        "label": {
            "R-responsive enhancer region": "DNA",
            "EB1 -binding site": "DNA",
            "EB1": "protein",
            "ZRE-B": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample2: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample3: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample4: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample7: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample8: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample9: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample10: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample13: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample14: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample15: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample16: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .\nAnswer:\n"
    },
    {
        "idx": 1622,
        "sentence": "Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.",
        "label": {
            "gamma interferon": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample2: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample5: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample6: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample9: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample10: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample11: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample12: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample13: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample14: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample15: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample16: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.\nAnswer:\n"
    },
    {
        "idx": 1393,
        "sentence": "This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .",
        "label": {
            "second enhancer": "DNA",
            "T-cell activation response element": "DNA",
            "enhancer": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample4: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample5: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample6: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample7: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample8: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample9: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample10: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample11: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample12: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample13: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample14: These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells .\nTRFs set: ['kinase', 'thymocytes', 'lymphocytes', 'cell', 'tyrosine']\n>>>\nExample15: Interleukin 2 and T cell antigen receptor signals converge upon serine 727 .\nTRFs set: ['kinase', 'tyrosine', 'phosphorylation', 'lymphocytes', 'thymocytes']\n>>>\nExample16: The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region .\nTRFs set: ['NF', 'promoter', 'enhancer', 'mRNA', 'RNAs']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .\nAnswer:\n"
    },
    {
        "idx": 1221,
        "sentence": "To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .",
        "label": {
            "mouse osteocalcin gene": "DNA",
            "promoter": "DNA",
            "osteoblast-specific cis-acting elements": "DNA",
            "trans-acting factors": "protein",
            "osteoblast-specific gene": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample2: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample3: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample4: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample7: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample8: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample9: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample10: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample11: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample12: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample13: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample14: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample15: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample16: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .\nAnswer:\n"
    },
    {
        "idx": 130,
        "sentence": "At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .",
        "label": {
            "TREp": "DNA",
            "TR": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample2: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample3: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample4: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample5: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample6: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample7: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample8: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample9: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample10: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample11: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample12: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample13: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample14: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample15: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample16: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .\nAnswer:\n"
    },
    {
        "idx": 788,
        "sentence": "The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).",
        "label": {
            "mineralocorticoid receptors": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample2: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample3: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample4: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample5: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample6: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample7: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample8: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample9: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample10: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample11: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample12: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample13: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n>>>\nExample14: A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1 , FVC , and peak expiratory flow ( PEF ) after oral prednisolone .\nTRFs set: ['endobronchial', 'patients', 'cryptococcal', 'FP', 'peripheral']\n>>>\nExample15: The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults .\nTRFs set: ['patients', 'peripheral', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample16: Membrane receptors for aldosterone : a novel pathway for mineralocorticoid action .\nTRFs set: ['kinase', 'monocytes', 'activation', 'promonocytic', 'mRNA']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).\nAnswer:\n"
    },
    {
        "idx": 781,
        "sentence": "Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample2: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample3: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample4: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample5: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample6: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample7: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample8: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample9: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample10: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample11: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample12: Eosinophils play an important role in the effector phase of allergic inflammation .\nTRFs set: ['lymphocytes', 'neutrophils', 'leukocytes', 'macrophages', 'monocytes']\n>>>\nExample13: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample14: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample15: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .\nAnswer:\n"
    },
    {
        "idx": 1220,
        "sentence": "A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .",
        "label": {
            "PEBP2 alpha/AML-1-related factor": "protein",
            "osteocalcin promoter": "DNA",
            "osteoblast-specific cis-acting element": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample2: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample3: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample4: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample5: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample6: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample7: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample8: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample9: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample10: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample11: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample12: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample13: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample14: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample15: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample16: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .\nAnswer:\n"
    },
    {
        "idx": 958,
        "sentence": "Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .",
        "label": {
            "B-cell-specific genes": "DNA",
            "BSAP": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample2: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample3: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample4: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample5: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample6: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample7: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample8: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample9: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample10: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample11: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample12: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample13: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample14: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample15: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample16: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .\nAnswer:\n"
    },
    {
        "idx": 1083,
        "sentence": "These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .",
        "label": {
            "cytokine": "protein",
            "NF kappa B": "protein",
            "PBMC": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample2: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample3: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample4: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample5: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample6: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample7: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample8: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample9: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample10: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample11: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample12: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample13: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample14: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample15: Transforming growth factor-beta ( TGF-beta ) inhibits B cell Ig secretion and reduces B cell membrane Ig expression .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'mRNA', 'cells']\n>>>\nExample16: Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'activation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .\nAnswer:\n"
    },
    {
        "idx": 514,
        "sentence": "Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .",
        "label": {
            "globin gene": "DNA",
            "enhancer": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample2: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample5: Although erythropoietin ( Epo ) is essential for the production of mature red blood cells , the cooperation with other factors is required for a proper balance between progenitor proliferation and differentiation .\nTRFs set: ['blood', 'cells', 'promoter', 'tyrosine', 'lymphocytes']\n>>>\nExample6: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample9: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample10: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample11: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample12: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample13: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample14: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample15: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample16: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .\nAnswer:\n"
    },
    {
        "idx": 1133,
        "sentence": "Both LCLs were found by EM to produce RVLP and EBV particles .",
        "label": {
            "LCLs": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Both LCLs were found by EM to produce RVLP and EBV particles .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample2: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample3: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample4: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample5: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample6: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample7: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample8: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample9: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample10: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample11: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample12: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample13: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample14: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample15: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample16: ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\nTRFs set: ['lymphocytes', 'promonocytic', 'monocytes', 'thymocytes', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Both LCLs were found by EM to produce RVLP and EBV particles .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Both LCLs were found by EM to produce RVLP and EBV particles .\nAnswer:\n"
    },
    {
        "idx": 1762,
        "sentence": "Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.",
        "label": {
            "IL-2": "protein",
            "early gene": "DNA",
            "NF-kappa B": "protein",
            "Oct1": "protein",
            "transcription factors": "protein",
            "NF-AT": "protein",
            "AP-1": "protein",
            "IL-2 gene": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample2: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample3: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample4: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample11: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample12: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample13: While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\nTRFs set: ['kinase', 'promoter', 'phosphorylation', 'activation', 'enhancer']\n>>>\nExample14: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample15: These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT .\nTRFs set: ['cells', 'kinase', 'thymocytes', 'activation', 'cell']\n>>>\nExample16: Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'lymphocytes', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.\nAnswer:\n"
    },
    {
        "idx": 23,
        "sentence": "Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .",
        "label": {
            "mutant E6 motif": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample2: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample3: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample4: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample5: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample6: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample7: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample8: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample9: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample10: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample11: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample12: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample13: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample14: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample15: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample16: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .\nAnswer:\n"
    },
    {
        "idx": 1476,
        "sentence": "Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .",
        "label": {
            "AP-1 protein": "protein",
            "c-Jun": "protein",
            "I kappa B": "protein",
            "NF-kappa B": "protein",
            "cytoplasmic inhibitor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample2: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample3: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample4: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample5: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample6: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample7: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample8: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample9: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample10: Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\nTRFs set: ['promoter', 'activation', 'mRNA', 'kinase', 'genes']\n>>>\nExample11: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample12: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample13: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample14: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample15: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample16: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .\nAnswer:\n"
    },
    {
        "idx": 234,
        "sentence": "A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .",
        "label": {
            "cultured": "cell_line",
            "primary cells": "cell_type",
            "adenovirus E2 promoter": "DNA",
            "beta-galactosidase gene": "DNA",
            "beta-galactosidase": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample2: In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.\nTRFs set: ['promonocytic', 'lymphocytes', 'monocytes', 'macrophages', 'mRNA']\n>>>\nExample3: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample4: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample5: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample6: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample7: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample8: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample9: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample10: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample11: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample12: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample13: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample14: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample15: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample16: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .\nAnswer:\n"
    },
    {
        "idx": 1396,
        "sentence": "NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .",
        "label": {
            "hematopoietic progenitor cell line": "cell_line",
            "NF-M": "protein",
            "chicken C/EBP beta": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample2: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample3: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample4: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample5: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample6: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample7: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample8: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample9: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample10: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample11: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample12: Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\nTRFs set: ['kinase', 'neutrophils', 'activation', 'NF', 'macrophages']\n>>>\nExample13: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample14: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample15: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample16: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .\nAnswer:\n"
    },
    {
        "idx": 1812,
        "sentence": "The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .",
        "label": {
            "G-protein coupled chemokine receptors": "protein",
            "chemokine receptors": "protein",
            "G-protein": "protein",
            "receptor EBI1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample2: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample3: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample4: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample5: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample6: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample7: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample8: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample9: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample10: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample11: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample12: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample13: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample14: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample15: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample16: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .\nAnswer:\n"
    },
    {
        "idx": 1099,
        "sentence": "Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .",
        "label": {
            "monocyte mitochondrial 1 alpha-hydroxylase": "protein",
            "monocyte": "cell_type",
            "microtubule": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample2: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample3: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample4: Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes .\nTRFs set: ['monocytes', 'macrophages', 'kinase', 'blood', 'cells']\n>>>\nExample5: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample6: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample7: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample8: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample9: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample10: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample11: When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\nTRFs set: ['thymocytes', 'monocytes', 'lymphocytes', 'macrophages', 'THP']\n>>>\nExample12: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample13: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample14: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample15: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample16: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .\nAnswer:\n"
    },
    {
        "idx": 1537,
        "sentence": "Furthermore, we identified a repression domain at the N-terminus of Oct-2a .",
        "label": {
            "Oct-2a": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample2: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample3: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample4: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample5: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample6: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample7: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample8: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample9: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample12: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample13: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample14: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample15: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample16: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Furthermore, we identified a repression domain at the N-terminus of Oct-2a .\nAnswer:\n"
    },
    {
        "idx": 1574,
        "sentence": "CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .",
        "label": {
            "receptors": "protein",
            "eosinophils": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Eosinophils play an important role in the effector phase of allergic inflammation .\nTRFs set: ['lymphocytes', 'neutrophils', 'leukocytes', 'macrophages', 'monocytes']\n>>>\nExample2: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample3: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample4: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample5: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample6: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample7: In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'endobronchial', 'gene']\n>>>\nExample8: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample9: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample10: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample11: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample12: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample13: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample14: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample15: To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs , and identified a negative element from bp -267 to -246 of the gp91phox gene , the deletion of which caused an 83% increase in promoter activity .\nTRFs set: ['promoter', 'gene', 'enhancer', 'kinase', 'genes']\n>>>\nExample16: This phenomenon is mediated, in part, through inducible expression of the CXC chemokine , interleukin-8 (IL-8).\nTRFs set: ['kinase', 'monocytes', 'macrophages', 'leukocytes', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .\nAnswer:\n"
    },
    {
        "idx": 1312,
        "sentence": "A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.",
        "label": {
            "HMG-1": "protein",
            "C-terminal HMG box": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample2: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample3: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample7: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample8: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample9: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample10: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample11: This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .\nTRFs set: ['kinase', 'monocytes', 'promonocytic', 'mRNA', 'macrophages']\n>>>\nExample12: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample13: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample14: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample15: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample16: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.\nAnswer:\n"
    },
    {
        "idx": 601,
        "sentence": "To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .",
        "label": {
            "murine IgH enhancer": "DNA",
            "putative additional lymphoid-specific transcription factor": "protein",
            "octamer (OCTA)-nucleotide motif": "DNA",
            "NF-microB": "protein",
            "enhancer elements": "DNA",
            "immunoglobulin heavy-chain (IgH) gene": "DNA",
            "binding site": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample2: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample3: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample4: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample5: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample6: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample7: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample11: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample12: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample13: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample14: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample15: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample16: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .\nAnswer:\n"
    },
    {
        "idx": 890,
        "sentence": "Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample2: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample3: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample4: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample5: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample6: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample7: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample8: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample9: We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'kappa', 'RNAs']\n>>>\nExample10: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample11: This hybrid clone, designated NR2 , was characterized by several methods, including PCR , with eight pairs of oligonucleotides mapped to Chr 20 : D20S5 , D20S41 , D20S42 , D20S56 , D20S57 , D20S58 , adenosine deaminase ( ADA ), and Prion protein ( PRIP ); Restriction Fragment Length Polymorphism ( RFLP ) analyses with four genomic anonymous probes ( D20S5 , cD3H12 , D20S17 , D20S18 ); and fluorescent in situ hybridization ( FISH ) with total human DNA and D20Z1 , a sequence specific to the human Chr 20 centromere , as probes.\nTRFs set: ['gene', 'clones', 'RNAs', 'genes', 'mRNA']\n>>>\nExample12: Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population , while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\nTRFs set: ['promonocytic', 'monocytes', 'kinase', 'lymphocytes', 'thymocytes']\n>>>\nExample13: Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development .\nTRFs set: ['promonocytic', 'cryptococcal', 'cells', 'monocytes', 'lymphocytes']\n>>>\nExample14: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n>>>\nExample15: A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction , but also abolishes most of the VitD3 induction of CD14 expression .\nTRFs set: ['promoter', 'THP', 'kinase', 'phosphorylation', 'mRNA']\n>>>\nExample16: CONCLUSION: Our results show that the tested agents (except indomethacin ) are inhibitors of the T cell-mediated immune response , as expected, that aspirin is an effective suppressor of adhesion molecule expression , and that all three agents can induce Hsp60 in HUVECs .\nTRFs set: ['monocytes', 'THP', 'lymphocytes', 'kinase', 'macrophages']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).\nAnswer:\n"
    },
    {
        "idx": 323,
        "sentence": "The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .",
        "label": {
            "Epstein-Barr virus ( EBV ) ORI1yt enhancer": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample2: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample3: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample4: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample5: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample6: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample7: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample8: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample9: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample10: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample11: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample12: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample13: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample14: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample15: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample16: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .\nAnswer:\n"
    },
    {
        "idx": 929,
        "sentence": "The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .",
        "label": {
            "ORF": "DNA",
            "272 carboxy-terminal amino acids": "protein",
            "ets-1": "protein",
            "human ets-1 protein": "protein",
            "813-bp open reading frame": "DNA",
            "cDNA sequence": "DNA",
            "amino acid sequence": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample2: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample5: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample6: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample7: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample8: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample9: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample10: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample11: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample12: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample13: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample14: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n>>>\nExample15: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample16: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .\nAnswer:\n"
    },
    {
        "idx": 6,
        "sentence": "Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .",
        "label": {
            "Platelet-activating factor": "protein",
            "oncogene": "DNA",
            "human B cell line": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample2: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample3: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample4: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample7: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample8: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample9: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample10: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample11: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample12: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample13: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample14: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample15: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample16: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .\nAnswer:\n"
    },
    {
        "idx": 1478,
        "sentence": "Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.",
        "label": {
            "activated T cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample2: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample3: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample4: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample5: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample6: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample7: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample8: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample9: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample10: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample11: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample12: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample13: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample14: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample15: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample16: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.\nAnswer:\n"
    },
    {
        "idx": 1793,
        "sentence": "The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample2: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample3: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample4: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample5: Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\nTRFs set: ['kinase', 'lymphocytes', 'promonocytic', 'promoter', 'thymocytes']\n>>>\nExample6: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample7: Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\nTRFs set: ['kinase', 'neutrophils', 'activation', 'NF', 'macrophages']\n>>>\nExample8: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample9: Eosinophils play an important role in the effector phase of allergic inflammation .\nTRFs set: ['lymphocytes', 'neutrophils', 'leukocytes', 'macrophages', 'monocytes']\n>>>\nExample10: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample11: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample12: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample13: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample14: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample15: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample16: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .\nAnswer:\n"
    },
    {
        "idx": 1473,
        "sentence": "Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .",
        "label": {
            "NF-kappa B": "protein",
            "T cells": "cell_type",
            "AP-1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample4: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample5: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample6: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample7: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample8: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample9: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample10: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample11: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample12: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample13: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample14: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample15: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample16: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .\nAnswer:\n"
    },
    {
        "idx": 539,
        "sentence": "PMA enhanced slightly the stimulatory effect of PHA .",
        "label": {
            "PHA": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'PMA enhanced slightly the stimulatory effect of PHA .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample2: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample3: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample4: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample5: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample6: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample7: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample8: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample9: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample10: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample11: The expression of NDP kinase was intense in KA and SCC compared with BCC .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'kappa', 'cells']\n>>>\nExample12: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample13: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample14: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample15: Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo -induced beta-globin expression , leading to a marked increase in haemoglobin production .\nTRFs set: ['enhancer', 'HeLa', 'promoter', 'mRNA', 'blood']\n>>>\nExample16: T cell blasts treated with PMA are now responsive to IFN-gamma .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'macrophages']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'PMA enhanced slightly the stimulatory effect of PHA .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: PMA enhanced slightly the stimulatory effect of PHA .\nAnswer:\n"
    },
    {
        "idx": 1025,
        "sentence": "NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .",
        "label": {
            "NFATc": "protein",
            "NK cells": "cell_type",
            "NFATc mRNA": "RNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample2: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample5: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample6: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample7: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample8: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample9: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample10: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample11: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample12: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample13: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample14: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample15: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample16: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .\nAnswer:\n"
    },
    {
        "idx": 1560,
        "sentence": "Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .",
        "label": {
            "human T helper (Th) clones": "cell_line",
            "CD30+ cells": "cell_line",
            "CD30": "protein",
            "NF-kappa B": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample2: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample3: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample4: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample7: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample8: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample11: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample12: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample13: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample14: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample15: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .\nAnswer:\n"
    },
    {
        "idx": 365,
        "sentence": "Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.",
        "label": {
            "c-jun": "DNA",
            "HL-60 cells": "cell_line",
            "untreated HL-60 cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample2: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample3: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample4: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample7: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample10: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample11: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample12: Expression of Tip and Tap in Jurkat-T cells induced dramatic cell aggregation.\nTRFs set: ['cells', 'thymocytes', 'cell', 'kinase', 'Jurkat']\n>>>\nExample13: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample14: These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT .\nTRFs set: ['cells', 'kinase', 'thymocytes', 'activation', 'cell']\n>>>\nExample15: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample16: Expression of either the TCL1 oncogene , or transcripts from its homologue MTCP1/c6.1B , in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'cells', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.\nAnswer:\n"
    },
    {
        "idx": 1039,
        "sentence": "Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .",
        "label": {
            "Peripheral blood mononuclear cells": "cell_type",
            "pbmc": "cell_type",
            "bone marrow cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample2: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample3: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample4: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample5: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample6: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample7: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample8: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample9: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample10: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample13: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample14: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample15: Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\nTRFs set: ['HeLa', 'cells', 'gene', 'genes', 'cell']\n>>>\nExample16: These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'mRNA', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .\nAnswer:\n"
    },
    {
        "idx": 217,
        "sentence": "Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .",
        "label": {
            "GCR": "protein",
            "glucocorticoid receptors": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample2: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample3: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample4: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample5: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample6: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample7: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample8: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample9: In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'endobronchial', 'gene']\n>>>\nExample10: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample11: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample12: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample13: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample14: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample15: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .\nAnswer:\n"
    },
    {
        "idx": 1782,
        "sentence": "In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .",
        "label": {
            "Id3": "protein",
            "resting PBL": "cell_type",
            "Id3 mRNA": "RNA",
            "PBL": "cell_type",
            "Id2": "protein",
            "Id2 mRNA": "RNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample2: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample5: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample8: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample9: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample10: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample11: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample12: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample13: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample14: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample15: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample16: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .\nAnswer:\n"
    },
    {
        "idx": 1280,
        "sentence": "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.",
        "label": {
            "NF-kappa B": "protein",
            "TATA element": "DNA",
            "transcription factors": "protein",
            "CD69": "protein",
            "AP-1": "protein",
            "30 base pairs upstream": "DNA",
            "CD69 gene": "DNA",
            "5'-flanking region": "DNA",
            "transcription initiation site": "DNA",
            "Egr-1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample2: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample5: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample6: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample7: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample8: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample9: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample10: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample11: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample12: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample13: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample14: These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells .\nTRFs set: ['kinase', 'thymocytes', 'lymphocytes', 'cell', 'tyrosine']\n>>>\nExample15: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample16: This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cell', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.\nAnswer:\n"
    },
    {
        "idx": 611,
        "sentence": "Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample2: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample3: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample4: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample5: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample6: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample7: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample8: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample9: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample10: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample11: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample12: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample13: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample14: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample15: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample16: Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'genes', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.\nAnswer:\n"
    },
    {
        "idx": 1723,
        "sentence": "In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .",
        "label": {
            "tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA",
            "NF-kappa B": "protein",
            "tumor necrosis factor-alpha": "protein",
            "TNF-alpha": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample2: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample3: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample4: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample5: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample6: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample7: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample8: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample9: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample10: When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\nTRFs set: ['thymocytes', 'monocytes', 'lymphocytes', 'macrophages', 'THP']\n>>>\nExample11: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample12: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample13: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample14: T cell blasts treated with PMA are now responsive to IFN-gamma .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'macrophages']\n>>>\nExample15: Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'activation', 'cells']\n>>>\nExample16: To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils .\nTRFs set: ['neutrophils', 'macrophages', 'kinase', 'monocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .\nAnswer:\n"
    },
    {
        "idx": 1308,
        "sentence": "Two groups of HMG box proteins are distinguished.",
        "label": {
            "HMG box proteins": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Two groups of HMG box proteins are distinguished.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample2: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample3: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample4: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample5: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample6: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample9: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample10: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample11: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample12: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample13: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample14: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample15: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample16: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Two groups of HMG box proteins are distinguished.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Two groups of HMG box proteins are distinguished.\nAnswer:\n"
    },
    {
        "idx": 765,
        "sentence": "Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample2: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample3: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample4: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample5: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample6: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample7: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample8: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample9: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample12: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample13: In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'endobronchial', 'gene']\n>>>\nExample14: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample15: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.\nAnswer:\n"
    },
    {
        "idx": 1561,
        "sentence": "In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .",
        "label": {
            "CD30": "protein",
            "NF-kappa B complexes": "protein",
            "p65 RelA": "protein",
            "p50 NF-kappa B1": "protein",
            "NF-kappa B": "protein",
            "transcription factors": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample2: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample3: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample4: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample5: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample6: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample7: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample8: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample9: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample10: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample11: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample12: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample13: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample14: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample15: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample16: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .\nAnswer:\n"
    },
    {
        "idx": 330,
        "sentence": "ZRE-B is therefore not part of the R- inducible enhancer .",
        "label": {
            "ZRE-B": "DNA",
            "R- inducible enhancer": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'ZRE-B is therefore not part of the R- inducible enhancer .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample2: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample3: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample4: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample5: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample6: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample7: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample8: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample9: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample10: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample11: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample12: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample13: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample14: Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'RNAs', 'cell']\n>>>\nExample15: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample16: The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs .\nTRFs set: ['mRNA', 'RNAs', 'gene', 'promoter', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'ZRE-B is therefore not part of the R- inducible enhancer .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: ZRE-B is therefore not part of the R- inducible enhancer .\nAnswer:\n"
    },
    {
        "idx": 1104,
        "sentence": "Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample2: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample3: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample4: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample5: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample6: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample7: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample10: Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample11: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample12: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample13: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample14: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample15: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample16: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.\nAnswer:\n"
    },
    {
        "idx": 1594,
        "sentence": "Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .",
        "label": {
            "Jurkat cells": "cell_line",
            "NF-kappa B -activating cytokine": "protein",
            "Human IL4 promoter": "DNA",
            "tumor necrosis factor alpha": "protein",
            "RelA -overexpressing cells": "cell_line",
            "NF-kappa B": "protein",
            "RelA": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample2: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample3: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample4: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample5: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample8: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample9: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample10: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample11: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample12: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample13: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample14: Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\nTRFs set: ['kinase', 'tyrosine', 'lymphocytes', 'thymocytes', 'gene']\n>>>\nExample15: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample16: Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'activation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .\nAnswer:\n"
    },
    {
        "idx": 1086,
        "sentence": "Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .",
        "label": {
            "NF-kappa B": "protein",
            "I kappa B alpha": "protein",
            "human I kappa B alpha protein": "protein",
            "mouse 70Z/3 cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample2: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample3: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample4: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample5: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample6: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample7: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample8: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample9: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample13: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample14: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample15: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample16: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .\nAnswer:\n"
    },
    {
        "idx": 1,
        "sentence": "When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.",
        "label": {
            "homeodomain": "DNA",
            "HB24": "DNA",
            "Drosophila homeodomain": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample2: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample3: Like Drosophila Toll , human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat ( LRR ) domain , and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor .\nTRFs set: ['mRNA', 'kinase', 'cells', 'cell', 'tyrosine']\n>>>\nExample4: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample5: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample6: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample9: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample10: These two related genes share the evolutionarily conserved region encoding the Runt domain .\nTRFs set: ['genes', 'gene', 'kinase', 'RNAs', 'mRNA']\n>>>\nExample11: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample12: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample13: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample14: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample15: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample16: Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\nTRFs set: ['blood', 'cells', 'gene', 'monocytes', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.\nAnswer:\n"
    },
    {
        "idx": 1226,
        "sentence": "Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .",
        "label": {
            "transcription factors": "protein",
            "T-cell nuclear extract-DNA complexes": "protein",
            "OSF2": "protein",
            "osteoblast nuclear extract-DNA complexes": "protein",
            "PEBP2 alpha factors": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample2: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample3: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample4: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample5: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample6: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample7: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample8: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample9: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample10: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample11: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample12: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample13: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample14: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample15: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample16: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .\nAnswer:\n"
    },
    {
        "idx": 663,
        "sentence": "The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n>>>\nExample2: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample3: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample4: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample5: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample6: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample7: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample8: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample9: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample10: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample11: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample12: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample13: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample14: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample15: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample16: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .\nAnswer:\n"
    },
    {
        "idx": 1000,
        "sentence": "Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.",
        "label": {
            "HSF2": "protein",
            "HSF3": "protein",
            "HSFs": "protein",
            "HSF1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample2: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample3: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample6: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample7: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample8: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample9: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample10: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample11: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample12: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample13: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample14: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample15: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample16: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.\nAnswer:\n"
    },
    {
        "idx": 39,
        "sentence": "Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .",
        "label": {
            "KBF1": "protein",
            "NF-kappa B": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample2: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample3: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample4: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample5: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample6: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample7: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample8: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample9: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample10: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample11: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample12: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample13: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample14: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample15: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample16: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .\nAnswer:\n"
    },
    {
        "idx": 229,
        "sentence": "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .",
        "label": {
            "B-cell line": "cell_line",
            "IM-9": "cell_line",
            "GR": "protein",
            "CVZ 's binding sites": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample2: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample3: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample4: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample5: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample8: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample9: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample10: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample11: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample12: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample13: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample14: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample15: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample16: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .\nAnswer:\n"
    },
    {
        "idx": 743,
        "sentence": "Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .",
        "label": {
            "erythroid cell transcription factor": "protein",
            "non-erythroid cells": "cell_type",
            "EF1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample2: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample3: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample4: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample5: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample6: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample9: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample10: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample11: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample12: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample13: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample14: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample15: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample16: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .\nAnswer:\n"
    },
    {
        "idx": 1799,
        "sentence": "These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .",
        "label": {
            "GAS": "DNA",
            "IFN-gamma-activated sequence": "DNA",
            "STAT proteins": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample2: Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\nTRFs set: ['kinase', 'phosphorylation', 'neutrophils', 'promonocytic', 'enhancer']\n>>>\nExample3: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample4: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample5: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample8: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample11: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample12: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample13: Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\nTRFs set: ['promoter', 'activation', 'mRNA', 'kinase', 'genes']\n>>>\nExample14: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample15: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample16: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .\nAnswer:\n"
    },
    {
        "idx": 1703,
        "sentence": "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .",
        "label": {
            "E1A": "protein",
            "IFN": "protein",
            "adenovirus-transformed cells": "cell_line",
            "IFN -activated NK cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample2: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample3: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample4: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample5: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample6: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample7: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample8: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample9: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample10: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample11: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample12: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample13: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample14: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample15: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample16: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .\nAnswer:\n"
    },
    {
        "idx": 629,
        "sentence": "Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .",
        "label": {
            "progesterone receptor": "protein",
            "CD8+ cells": "cell_line",
            "lymphocytes": "cell_line",
            "progesterone receptor -bearing cells": "cell_line",
            "CD4+ cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample2: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample3: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample4: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample5: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample6: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample9: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample10: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample13: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample14: Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'cells', 'leukocytes']\n>>>\nExample15: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample16: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .\nAnswer:\n"
    },
    {
        "idx": 490,
        "sentence": "Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .",
        "label": {
            "lymphokine genes": "DNA",
            "interleukin-2": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample4: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample5: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample8: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\nTRFs set: ['kinase', 'lymphocytes', 'promonocytic', 'promoter', 'thymocytes']\n>>>\nExample11: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample12: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample13: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample14: In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'endobronchial', 'gene']\n>>>\nExample15: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample16: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .\nAnswer:\n"
    },
    {
        "idx": 118,
        "sentence": "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .",
        "label": {
            "SCL": "protein",
            "SCL 5' regulatory region": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample2: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample3: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample4: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample5: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample6: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample7: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample8: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample9: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample10: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample11: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample12: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample13: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample14: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n>>>\nExample15: By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\nTRFs set: ['clones', 'gene', 'genes', 'cells', 'phosphorylation']\n>>>\nExample16: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .\nAnswer:\n"
    },
    {
        "idx": 493,
        "sentence": "Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .",
        "label": {
            "NFAT-1 complex": "protein",
            "mitogen-inducible DNA-binding complexes": "protein",
            "kappa B complex": "protein",
            "interleukin-2": "protein",
            "interleukin-2 enhancer": "DNA",
            "HIV enhancer": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample2: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample3: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample4: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample5: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample6: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample7: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample8: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample9: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample13: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample14: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample15: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n>>>\nExample16: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .\nAnswer:\n"
    },
    {
        "idx": 1798,
        "sentence": "In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .",
        "label": {
            "purified human peripheral blood T cells": "cell_type",
            "anti-CD3 Abs": "protein",
            "nuclear STAT proteins": "protein",
            "T cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample2: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample3: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample4: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample5: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample6: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample7: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample8: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample9: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample10: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample13: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample14: Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\nTRFs set: ['kinase', 'phosphorylation', 'neutrophils', 'promonocytic', 'enhancer']\n>>>\nExample15: Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'cells', 'blood']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .\nAnswer:\n"
    },
    {
        "idx": 175,
        "sentence": "To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.",
        "label": {
            "blood mononuclear cells": "cell_type",
            "uncultured cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample4: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample5: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample6: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample7: In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'endobronchial', 'gene']\n>>>\nExample8: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample9: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample10: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample11: Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes .\nTRFs set: ['monocytes', 'macrophages', 'kinase', 'blood', 'cells']\n>>>\nExample12: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample13: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample14: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample15: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.\nAnswer:\n"
    },
    {
        "idx": 1498,
        "sentence": "Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.",
        "label": {
            "lymphoblasts": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample2: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample3: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample4: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample5: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample6: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample7: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample8: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample9: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample10: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample11: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample12: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample13: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample14: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample15: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample16: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.\nAnswer:\n"
    },
    {
        "idx": 995,
        "sentence": "The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample2: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample3: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample4: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample5: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample6: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample7: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample8: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample9: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample10: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample11: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample12: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample13: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample14: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample15: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample16: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .\nAnswer:\n"
    },
    {
        "idx": 1671,
        "sentence": "Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .",
        "label": {
            "IL-6 neutralizing antibodies": "protein",
            "IL-6": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample2: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample3: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample4: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample5: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample6: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample7: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample10: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample11: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample12: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample13: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample14: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample15: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample16: Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'activation', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .\nAnswer:\n"
    },
    {
        "idx": 141,
        "sentence": "TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .",
        "label": {
            "monocytic cells": "cell_type",
            "TNF-alpha": "protein",
            "HIV LTR": "DNA",
            "T cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample2: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample3: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample4: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample5: When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\nTRFs set: ['thymocytes', 'monocytes', 'lymphocytes', 'macrophages', 'THP']\n>>>\nExample6: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample7: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample8: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample9: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample10: Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'activation', 'cells']\n>>>\nExample11: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample12: Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'lymphocytes', 'gene']\n>>>\nExample13: Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample14: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample15: These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'lymphocytes']\n>>>\nExample16: We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'promoter', 'tyrosine']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .\nAnswer:\n"
    },
    {
        "idx": 1557,
        "sentence": "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .",
        "label": {
            "Hodgkin's disease -derived, T cell-like, CD30 + cells": "cell_line",
            "nuclear factor (NF)-kappa B": "protein",
            "M44": "protein",
            "L540 cells": "cell_line",
            "M67": "protein",
            "mAb": "protein",
            "agonistic anti- CD30 monoclonal antibodies": "protein",
            "CD30": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample2: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample3: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample4: In fact, mAb L243 but not the staphylococcal superantigens , staphylococcal exotoxin toxic shock syndrome toxin-I or staphylococcal enterotoxin B , regulate the NF-kappa B binding activity .\nTRFs set: ['kinase', 'kappa', 'lymphocytes', 'macrophages', 'cryptococcal']\n>>>\nExample5: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample6: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample7: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample8: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample9: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample10: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample11: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample12: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample13: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample14: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample15: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample16: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .\nAnswer:\n"
    },
    {
        "idx": 1090,
        "sentence": "Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.",
        "label": {
            "N terminus": "protein",
            "I kappa B alpha": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample2: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample5: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample6: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample7: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample8: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample9: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample10: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample11: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample12: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample13: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample14: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample15: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample16: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.\nAnswer:\n"
    },
    {
        "idx": 1568,
        "sentence": "The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .",
        "label": {
            "enzymes": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample2: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample3: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample4: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample5: We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\nTRFs set: ['monocytes', 'macrophages', 'THP', 'phosphorylation', 'tyrosine']\n>>>\nExample6: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample9: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample10: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample11: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample12: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample13: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample14: Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'cells', 'blood']\n>>>\nExample15: Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'genes', 'cells']\n>>>\nExample16: In response to hypoxia, sickle red blood cells ( SS RBC ) and leukocytes exhibit increased adherence to the vascular endothelium, while diapedesis of leukocytes through the blood vessel increases .\nTRFs set: ['leukocytes', 'blood', 'monocytes', 'cells', 'neutrophils']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .\nAnswer:\n"
    },
    {
        "idx": 257,
        "sentence": "Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample2: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample3: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample4: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample5: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample6: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample7: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample8: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample9: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample10: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample11: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample12: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample13: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample14: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample15: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample16: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .\nAnswer:\n"
    },
    {
        "idx": 262,
        "sentence": "This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .",
        "label": {
            "complementary DNA": "DNA",
            "c-jun proto-oncogene product": "protein",
            "palindromic target sequence": "DNA",
            "c-jun": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample2: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: These two related genes share the evolutionarily conserved region encoding the Runt domain .\nTRFs set: ['genes', 'gene', 'kinase', 'RNAs', 'mRNA']\n>>>\nExample5: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample6: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample7: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample8: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample9: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample10: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample11: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample12: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample13: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample14: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample15: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .\nAnswer:\n"
    },
    {
        "idx": 1351,
        "sentence": "Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample2: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample3: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample4: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample5: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample6: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample7: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample8: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample9: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample10: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample11: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample12: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample13: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample14: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample15: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample16: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .\nAnswer:\n"
    },
    {
        "idx": 973,
        "sentence": "To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .",
        "label": {
            "MZF-1": "DNA",
            "DNA binding domain": "protein",
            "yeast transactivator GAL4": "protein",
            "GAL4": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample2: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample3: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample4: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample5: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample6: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample7: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample8: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample9: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample10: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample11: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample12: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample13: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample14: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample15: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample16: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .\nAnswer:\n"
    },
    {
        "idx": 1125,
        "sentence": "This indicates that the CR of GR may be of functional significance.",
        "label": {
            "GR": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This indicates that the CR of GR may be of functional significance.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample2: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample3: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample4: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample5: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample6: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample7: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample8: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample9: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample10: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample11: This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .\nTRFs set: ['kinase', 'monocytes', 'promonocytic', 'mRNA', 'macrophages']\n>>>\nExample12: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample13: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample14: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n>>>\nExample15: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample16: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This indicates that the CR of GR may be of functional significance.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This indicates that the CR of GR may be of functional significance.\nAnswer:\n"
    },
    {
        "idx": 338,
        "sentence": "Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .",
        "label": {
            "T3R": "protein",
            "lymphocytes": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample2: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample3: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample6: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample7: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample8: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample9: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample10: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample13: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample14: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample15: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .\nAnswer:\n"
    },
    {
        "idx": 1080,
        "sentence": "However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample2: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample3: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample4: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample5: Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription .\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'RNAs', 'cell']\n>>>\nExample6: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample7: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample8: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample9: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample10: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample11: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample12: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample13: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample14: Although erythropoietin ( Epo ) is essential for the production of mature red blood cells , the cooperation with other factors is required for a proper balance between progenitor proliferation and differentiation .\nTRFs set: ['blood', 'cells', 'promoter', 'tyrosine', 'lymphocytes']\n>>>\nExample15: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample16: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .\nAnswer:\n"
    },
    {
        "idx": 1786,
        "sentence": "Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .",
        "label": {
            "coagulation protease": "protein",
            "tissue factor (TF) receptor": "protein",
            "plasma Factor VII/VIIa": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample2: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample3: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample4: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample5: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample6: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample7: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample8: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample9: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample12: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample13: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample14: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample15: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample16: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .\nAnswer:\n"
    },
    {
        "idx": 1242,
        "sentence": "LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .",
        "label": {
            "NF kappa B": "protein",
            "p50/p65 heterodimers": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample2: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample3: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample4: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample5: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample6: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample7: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample8: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample9: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample10: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample11: Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\nTRFs set: ['kinase', 'neutrophils', 'activation', 'NF', 'macrophages']\n>>>\nExample12: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample13: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample14: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample15: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample16: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .\nAnswer:\n"
    },
    {
        "idx": 866,
        "sentence": "T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .",
        "label": {
            "T cell": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample2: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample3: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample4: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample5: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample6: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample7: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample8: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample9: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample10: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample11: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample12: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample13: Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'genes', 'cells']\n>>>\nExample14: Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample15: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n>>>\nExample16: These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .\nAnswer:\n"
    },
    {
        "idx": 433,
        "sentence": "Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .",
        "label": {
            "regulatory regions": "DNA",
            "BSAP": "protein",
            "high-affinity binding site": "DNA",
            "B-lymphoid-specific genes": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample2: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample3: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample4: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample5: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample6: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample7: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample8: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample9: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample10: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample11: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample12: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample13: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample14: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample15: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample16: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .\nAnswer:\n"
    },
    {
        "idx": 1546,
        "sentence": "Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .",
        "label": {
            "platelet glycoprotein Ib alpha gene": "DNA",
            "GATA": "DNA",
            "Ets binding motifs": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample2: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample3: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample4: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample5: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample6: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample7: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample8: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample9: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample10: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample11: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample12: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample13: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample14: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample15: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample16: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .\nAnswer:\n"
    },
    {
        "idx": 1412,
        "sentence": "We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample2: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample5: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample8: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample9: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample10: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample13: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample14: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample15: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample16: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .\nAnswer:\n"
    },
    {
        "idx": 411,
        "sentence": "There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).",
        "label": {
            "VDR": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample2: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample3: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample4: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample5: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample6: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample7: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample8: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample9: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample10: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample11: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample12: Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo -induced beta-globin expression , leading to a marked increase in haemoglobin production .\nTRFs set: ['enhancer', 'HeLa', 'promoter', 'mRNA', 'blood']\n>>>\nExample13: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample14: Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\nTRFs set: ['promonocytic', 'monocytes', 'THP', 'thymocytes', 'neutrophils']\n>>>\nExample15: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample16: The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence .\nTRFs set: ['kinase', 'promoter', 'phosphorylation', 'enhancer', 'kappa']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).\nAnswer:\n"
    },
    {
        "idx": 1460,
        "sentence": "In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.",
        "label": {
            "multiple myeloma cell lines": "cell_line",
            "PU.1": "protein",
            "Pu box": "DNA",
            "differentiated, plasma cell-like B cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample2: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample3: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample4: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample5: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample6: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample7: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample12: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample13: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample14: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample15: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample16: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.\nAnswer:\n"
    },
    {
        "idx": 638,
        "sentence": "Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .",
        "label": {
            "CD3": "protein",
            "TCR": "protein",
            "VLA-5 fibronectin receptor": "protein",
            "fibronectin": "protein",
            "CD4 cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample2: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample3: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample4: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample5: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample6: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample7: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample8: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample9: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample10: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample11: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample12: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample13: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample14: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample15: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample16: ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\nTRFs set: ['lymphocytes', 'promonocytic', 'monocytes', 'thymocytes', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .\nAnswer:\n"
    },
    {
        "idx": 1375,
        "sentence": "We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .",
        "label": {
            "PBLs": "cell_type",
            "peripheral blood lymphocytes": "cell_type",
            "TCL1 mRNA": "RNA",
            "protein": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample2: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample3: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample4: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample5: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample6: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample7: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample8: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample9: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample10: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample11: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample12: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample13: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample14: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample15: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .\nAnswer:\n"
    },
    {
        "idx": 764,
        "sentence": "The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .",
        "label": {
            "CEM-C7": "cell_line",
            "CEM-C7 cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample3: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample4: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample5: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample6: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample7: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample8: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample9: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample10: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample11: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample12: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample13: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample14: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample15: Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\nTRFs set: ['blood', 'cells', 'gene', 'monocytes', 'promonocytic']\n>>>\nExample16: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .\nAnswer:\n"
    },
    {
        "idx": 897,
        "sentence": "The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .",
        "label": {
            "transcription of SV40 T-antigen": "protein",
            "NFAT-1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample2: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample5: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample6: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample7: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample8: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample9: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample12: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n>>>\nExample13: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample14: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample15: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample16: NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\nTRFs set: ['promoter', 'mRNA', 'enhancer', 'gene', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .\nAnswer:\n"
    },
    {
        "idx": 1842,
        "sentence": "Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .",
        "label": {
            "Ets-1": "protein",
            "TFE-3": "protein",
            "LEF-1": "protein",
            "enhancer-binding proteins": "protein",
            "Sp1": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample2: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample3: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample4: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample5: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample6: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample7: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample8: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample9: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample10: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample11: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample12: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample13: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample14: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample15: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample16: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .\nAnswer:\n"
    },
    {
        "idx": 1059,
        "sentence": "Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .",
        "label": {
            "NF-kappa B family": "protein",
            "Transcription factors": "protein",
            "I kappa B beta": "protein",
            "inhibitory I kappa B proteins": "protein",
            "I kappa B alpha": "protein",
            "NF-kappa B": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample2: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample3: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample4: Control of NF-kappa B activity by the I kappa B beta inhibitor .\nTRFs set: ['kinase', 'kappa', 'NF', 'enhancer', 'promoter']\n>>>\nExample5: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample6: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample9: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample10: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample11: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample12: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample13: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample14: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample15: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample16: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .\nAnswer:\n"
    },
    {
        "idx": 924,
        "sentence": "We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .",
        "label": {
            "hsp70": "protein",
            "untransformed steroid receptors": "protein",
            "hsp90": "protein",
            "p56": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample2: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample3: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample4: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample5: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample6: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample7: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample8: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample9: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample10: The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'RNAs']\n>>>\nExample11: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample12: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample13: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample14: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample15: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample16: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .\nAnswer:\n"
    },
    {
        "idx": 247,
        "sentence": "Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .",
        "label": {
            "Antigen B27": "protein",
            "glucocorticoid receptors": "protein",
            "blood lymphocytes": "cell_type",
            "lymphocytes": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample2: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample3: Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\nTRFs set: ['lymphocytes', 'leukocytes', 'tyrosine', 'thymocytes', 'blood']\n>>>\nExample4: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample5: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample6: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample7: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample8: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample9: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample10: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample11: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample12: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample13: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample16: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .\nAnswer:\n"
    },
    {
        "idx": 507,
        "sentence": "Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .",
        "label": {
            "TCF-2 alpha": "protein",
            "TCR alpha enhancer": "DNA",
            "CREB": "protein",
            "transcription factors": "protein",
            "T alpha 1": "protein",
            "TCR": "protein",
            "TCF-1 alpha": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample2: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample3: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample4: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample5: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample6: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample7: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample8: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample9: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample10: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample11: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample12: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample13: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample14: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample15: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample16: While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\nTRFs set: ['kinase', 'promoter', 'phosphorylation', 'activation', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .\nAnswer:\n"
    },
    {
        "idx": 460,
        "sentence": "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.",
        "label": {
            "HIV LTRs": "DNA",
            "regulatory elements": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample2: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample5: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample6: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample7: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample8: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample9: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample10: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample11: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample12: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample13: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample14: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample15: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample16: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.\nAnswer:\n"
    },
    {
        "idx": 131,
        "sentence": "Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .",
        "label": {
            "TRs": "protein",
            "carboxyl-terminus": "protein",
            "TR alpha 1": "protein",
            "nuclear proteins": "protein",
            "amino acid 210": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample2: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample3: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample4: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample5: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample8: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample9: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n>>>\nExample10: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample11: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample12: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample13: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample14: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample15: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample16: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .\nAnswer:\n"
    },
    {
        "idx": 692,
        "sentence": "The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .",
        "label": {
            "virally encoded transactivator protein": "protein",
            "Tax -response element": "DNA",
            "TRE": "DNA",
            "human T-cell leukemia virus type I ( HTLV-I ) promoter": "DNA",
            "Tax": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample2: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample3: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample4: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample5: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample9: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample10: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample11: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample12: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample13: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample14: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n>>>\nExample15: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample16: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .\nAnswer:\n"
    },
    {
        "idx": 43,
        "sentence": "T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .",
        "label": {
            "cysteine-rich antigen segments": "protein",
            "T-helper-cell determinants": "protein",
            "protein antigens": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample2: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample5: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample6: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample7: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample8: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample9: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample10: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample11: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample12: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample13: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample14: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample15: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample16: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .\nAnswer:\n"
    },
    {
        "idx": 1204,
        "sentence": "Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample2: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample3: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample4: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample5: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample6: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample7: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample8: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample9: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample10: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample11: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n>>>\nExample12: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample13: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n>>>\nExample14: A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1 , FVC , and peak expiratory flow ( PEF ) after oral prednisolone .\nTRFs set: ['endobronchial', 'patients', 'cryptococcal', 'FP', 'peripheral']\n>>>\nExample15: The ras-transformed lymphocytes displayed a fully functional IL-2r , as assessed by c-fos induction following treatment with IL-2 ; nevertheless, they were not growth stimulated by this lymphokine .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'promonocytic']\n>>>\nExample16: The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults .\nTRFs set: ['patients', 'peripheral', 'thymocytes', 'cells', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.\nAnswer:\n"
    },
    {
        "idx": 1134,
        "sentence": "Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .",
        "label": {
            "LCLs": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample2: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample3: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample4: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample5: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample6: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample7: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample10: In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.\nTRFs set: ['promonocytic', 'lymphocytes', 'monocytes', 'macrophages', 'mRNA']\n>>>\nExample11: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample12: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample13: The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\nTRFs set: ['kinase', 'tyrosine', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample14: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample15: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample16: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .\nAnswer:\n"
    },
    {
        "idx": 471,
        "sentence": "The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).",
        "label": {
            "lymphocyte nuclear T3 receptor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample2: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample3: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample4: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample9: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample10: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample11: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample12: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample13: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample14: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample15: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample16: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).\nAnswer:\n"
    },
    {
        "idx": 1205,
        "sentence": "Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample2: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample3: Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\nTRFs set: ['lymphocytes', 'cryptococcal', 'leukocytes', 'monocytes', 'kinase']\n>>>\nExample4: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample5: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample6: We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'kappa', 'promoter']\n>>>\nExample7: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample8: Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\nTRFs set: ['lymphocytes', 'cryptococcal', 'thymocytes', 'monocytes', 'leukocytes']\n>>>\nExample9: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample10: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample11: T cell blasts treated with PMA are now responsive to IFN-gamma .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'macrophages']\n>>>\nExample12: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n>>>\nExample13: The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\nTRFs set: ['thymocytes', 'promonocytic', 'THP', 'phosphorylation', 'kinase']\n>>>\nExample14: When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.\nTRFs set: ['promonocytic', 'mRNA', 'monocytes', 'cryptococcal', 'promoter']\n>>>\nExample15: DNA-binding phosphoproteins induced after T cell activation : effects of cyclosporin A .\nTRFs set: ['phosphorylation', 'kinase', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample16: The ras-transformed lymphocytes displayed a fully functional IL-2r , as assessed by c-fos induction following treatment with IL-2 ; nevertheless, they were not growth stimulated by this lymphokine .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .\nAnswer:\n"
    },
    {
        "idx": 14,
        "sentence": "Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .",
        "label": {
            "c-fos": "DNA",
            "nuclear proto-oncogenes": "DNA",
            "c-jun": "DNA",
            "platelet-activating factor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample2: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample3: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample4: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample5: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample8: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample9: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample10: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample11: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample12: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample13: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample14: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample15: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample16: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .\nAnswer:\n"
    },
    {
        "idx": 145,
        "sentence": "Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .",
        "label": {
            "nuclear proteins": "protein",
            "major histocompatibility complex (MHC) class II promoters": "DNA",
            "B cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample2: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample3: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample4: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample5: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample6: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample7: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample8: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample9: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample10: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample11: Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample12: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample13: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample14: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample15: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample16: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .\nAnswer:\n"
    },
    {
        "idx": 1449,
        "sentence": "DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.",
        "label": {
            "upstream stimulatory factor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample2: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample3: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample4: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample5: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample6: We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\nTRFs set: ['phosphorylation', 'kinase', 'activation', 'tyrosine', 'promoter']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample9: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample10: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample11: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample12: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample13: In fact, mAb L243 but not the staphylococcal superantigens , staphylococcal exotoxin toxic shock syndrome toxin-I or staphylococcal enterotoxin B , regulate the NF-kappa B binding activity .\nTRFs set: ['kinase', 'kappa', 'lymphocytes', 'macrophages', 'cryptococcal']\n>>>\nExample14: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample15: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample16: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.\nAnswer:\n"
    },
    {
        "idx": 1292,
        "sentence": "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .",
        "label": {
            "thromboxane receptor": "protein",
            "thromboxane receptor gene": "DNA",
            "CAT": "protein",
            "chloramphenicol acetyltransferase": "protein",
            "5' flanking region": "DNA",
            "thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids": "DNA",
            "K562 cells": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample2: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample3: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample4: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample5: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample6: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample7: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample8: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample9: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample10: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample11: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample12: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample13: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample14: Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\nTRFs set: ['promoter', 'phosphorylation', 'kinase', 'sites', 'activation']\n>>>\nExample15: This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cell', 'thymocytes']\n>>>\nExample16: While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\nTRFs set: ['kinase', 'promoter', 'phosphorylation', 'activation', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .\nAnswer:\n"
    },
    {
        "idx": 120,
        "sentence": "Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.",
        "label": {
            "RPMI 8402": "cell_line",
            "T cell lines": "cell_line",
            "CEM": "cell_line"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample2: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample3: The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\nTRFs set: ['mRNA', 'monocytes', 'promonocytic', 'kinase', 'neutrophils']\n>>>\nExample4: These two related genes share the evolutionarily conserved region encoding the Runt domain .\nTRFs set: ['genes', 'gene', 'kinase', 'RNAs', 'mRNA']\n>>>\nExample5: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample6: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample7: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample8: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample9: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample10: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample11: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample12: Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\nTRFs set: ['promoter', 'enhancer', 'gene', 'clones', 'mRNA']\n>>>\nExample13: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample14: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample15: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample16: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.\nAnswer:\n"
    },
    {
        "idx": 468,
        "sentence": "A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample2: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample3: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample4: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample5: By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\nTRFs set: ['clones', 'gene', 'genes', 'cells', 'phosphorylation']\n>>>\nExample6: Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\nTRFs set: ['phosphorylation', 'lymphocytes', 'kinase', 'blood', 'THP']\n>>>\nExample7: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample8: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample9: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample10: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample11: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample12: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample13: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample14: Expression of either the TCL1 oncogene , or transcripts from its homologue MTCP1/c6.1B , in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'cells', 'kinase']\n>>>\nExample15: Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1 .\nTRFs set: ['phosphorylation', 'promoter', 'enhancer', 'kinase', 'promonocytic']\n>>>\nExample16: A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1 , FVC , and peak expiratory flow ( PEF ) after oral prednisolone .\nTRFs set: ['endobronchial', 'patients', 'cryptococcal', 'FP', 'peripheral']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .\nAnswer:\n"
    },
    {
        "idx": 138,
        "sentence": "The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .",
        "label": {
            "beta interferon promoter": "DNA",
            "regulatory elements": "DNA",
            "HIV long terminal repeat": "DNA",
            "TNF-alpha": "protein",
            "LTR": "DNA",
            "reporter chloramphenicol acetyltransferase plasmids": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample2: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample3: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample4: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample5: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample6: Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'activation', 'cells']\n>>>\nExample7: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample8: Exposure to LPS or TNF led to differential patterns of IkappaB -alpha and IkappaB -epsilon disappearance from and reassembly with the signalsome, whereas IKK-alpha , IKK-beta , and NIK remained complex-associated.\nTRFs set: ['kinase', 'kappa', 'macrophages', 'RNAs', 'mRNA']\n>>>\nExample9: Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'lymphocytes', 'gene']\n>>>\nExample10: We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'kappa', 'RNAs']\n>>>\nExample11: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample12: We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'promoter', 'tyrosine']\n>>>\nExample13: We used reverse transcriptase -polymerase chain reaction to examine both fetal and term neonatal cord bloods for mRNA expression of three transcription factors implicated in T-cell activation : c-jun , c-fos , and NF kappa B ( p50 subunit ).\nTRFs set: ['mRNA', 'thymocytes', 'RNAs', 'promoter', 'blood']\n>>>\nExample14: First, we describe results demonstrating that mice inoculated with T-antigen-expressing plasmids produced antibodies , not only to T-antigen and DNA, but also to the DNA-binding eukaryotic transcription factors TATA-binding protein ( TBP ), and to the cAMP-response-element-binding protein ( CREB ).\nTRFs set: ['mRNA', 'gene', 'genes', 'thymocytes', 'lymphocytes']\n>>>\nExample15: DNA-binding and transcriptional regulatory properties of hepatic leukemia factor ( HLF ) and the t(17;19) acute lymphoblastic leukemia chimera E2A- HLF .\nTRFs set: ['lymphocytes', 'HeLa', 'enhancer', 'promoter', 'gene']\n>>>\nExample16: To understand the diminished T cell response to activation signals , we measured nucleoprotein DNA-binding activities regulating gene expression during T cell activation using the electrophoretic mobility shift assay .\nTRFs set: ['activation', 'thymocytes', 'phosphorylation', 'cells', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .\nAnswer:\n"
    },
    {
        "idx": 64,
        "sentence": "Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .",
        "label": {
            "IFN beta promoter deletions": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample2: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample3: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample4: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample5: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample6: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample7: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample8: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample9: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample10: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample11: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample12: Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\nTRFs set: ['HeLa', 'cells', 'gene', 'genes', 'cell']\n>>>\nExample13: We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'kappa', 'RNAs']\n>>>\nExample14: NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\nTRFs set: ['promoter', 'mRNA', 'enhancer', 'gene', 'NF']\n>>>\nExample15: We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'promoter', 'tyrosine']\n>>>\nExample16: Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\nTRFs set: ['lymphocytes', 'promoter', 'promonocytic', 'thymocytes', 'mRNA']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .\nAnswer:\n"
    },
    {
        "idx": 1760,
        "sentence": "This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample2: Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'monocytes', 'blood']\n>>>\nExample3: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample4: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample5: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample6: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample7: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample8: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample9: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample12: We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\nTRFs set: ['lymphocytes', 'thymocytes', 'kinase', 'promonocytic', 'monocytes']\n>>>\nExample13: Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'tyrosine']\n>>>\nExample14: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample15: While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\nTRFs set: ['kinase', 'promoter', 'phosphorylation', 'activation', 'enhancer']\n>>>\nExample16: To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils .\nTRFs set: ['neutrophils', 'macrophages', 'kinase', 'monocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .\nAnswer:\n"
    },
    {
        "idx": 676,
        "sentence": "The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein",
            "interleukin 2 ( IL-2 ) gene promoter": "DNA",
            "T-cell": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample2: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample3: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample4: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample5: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample6: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample7: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample8: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample9: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample10: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample11: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample12: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample13: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample16: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .\nAnswer:\n"
    },
    {
        "idx": 1052,
        "sentence": "Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.",
        "label": {
            "IL-2R alpha": "protein",
            "SEA": "protein",
            "IL-2R gamma": "protein",
            "SEB": "protein",
            "IL-2R beta": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample2: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample3: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample4: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample5: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\nTRFs set: ['mRNA', 'enhancer', 'promoter', 'genes', 'kinase']\n>>>\nExample8: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample9: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample10: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample11: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample12: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample13: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample14: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample15: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample16: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.\nAnswer:\n"
    },
    {
        "idx": 487,
        "sentence": "Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.",
        "label": {
            "human monocytes": "cell_type",
            "normal human monocytes": "cell_type",
            "M-CSF": "protein",
            "immediate early response genes": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample2: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample3: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample4: Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'lymphocytes', 'thymocytes']\n>>>\nExample5: These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'cell', 'leukocytes']\n>>>\nExample6: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample7: The effects of G-CSF are mediated by binding to specific, high affinity receptors .\nTRFs set: ['kinase', 'promonocytic', 'monocytes', 'blood', 'lymphocytes']\n>>>\nExample8: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample9: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample12: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample13: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample14: In monocytes, the virus was bound to the surface without being internalized.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'cells']\n>>>\nExample15: Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'thymocytes', 'lymphocytes']\n>>>\nExample16: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.\nAnswer:\n"
    },
    {
        "idx": 570,
        "sentence": "Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample2: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample3: Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample4: Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\nTRFs set: ['monocytes', 'promonocytic', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample5: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample8: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample9: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample10: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample11: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample12: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample13: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample14: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample15: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.\nAnswer:\n"
    },
    {
        "idx": 1370,
        "sentence": "Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .",
        "label": {
            "CD28": "protein",
            "anti- CD28 MoAb": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample2: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample3: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample4: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample5: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample6: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample7: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample8: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample9: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample10: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample11: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample12: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample13: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample14: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample15: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample16: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .\nAnswer:\n"
    },
    {
        "idx": 994,
        "sentence": "The role of BSAP ( Pax-5 ) in B-cell development .",
        "label": {
            "BSAP": "protein",
            "Pax-5": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The role of BSAP ( Pax-5 ) in B-cell development .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample2: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample3: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample4: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample5: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample6: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample7: IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\nTRFs set: ['monocytes', 'lymphocytes', 'leukocytes', 'kinase', 'thymocytes']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample11: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample12: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample13: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample14: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample15: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample16: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The role of BSAP ( Pax-5 ) in B-cell development .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The role of BSAP ( Pax-5 ) in B-cell development .\nAnswer:\n"
    },
    {
        "idx": 438,
        "sentence": "This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).",
        "label": {
            "OTF factors": "protein",
            "nuclear proteins": "protein",
            "sequence motif": "DNA",
            "octamer transcription factors": "protein",
            "Oct": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample2: Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\nTRFs set: ['promoter', 'activation', 'mRNA', 'kinase', 'genes']\n>>>\nExample3: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample4: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample5: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample6: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample7: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample8: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample9: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample10: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample11: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample12: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample13: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample14: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample15: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample16: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).\nAnswer:\n"
    },
    {
        "idx": 270,
        "sentence": "There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample2: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample7: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample8: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample9: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample10: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample11: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample12: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample13: Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .\nTRFs set: ['gene', 'enhancer', 'genes', 'mRNA', 'promoter']\n>>>\nExample14: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample15: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample16: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .\nAnswer:\n"
    },
    {
        "idx": 1481,
        "sentence": "We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample2: We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\nTRFs set: ['promoter', 'lymphocytes', 'elements', 'enhancer', 'kinase']\n>>>\nExample3: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample4: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample5: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample6: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample7: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample8: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample9: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample10: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample11: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample12: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample13: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample14: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample15: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample16: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .\nAnswer:\n"
    },
    {
        "idx": 1807,
        "sentence": "We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .",
        "label": {
            "cell genes": "DNA",
            "cyclin E": "DNA",
            "cyclin D2": "DNA",
            "CD23": "DNA",
            "cdc-2": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample2: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample3: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample4: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample5: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample6: Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\nTRFs set: ['lymphocytes', 'mRNA', 'gene', 'thymocytes', 'monocytes']\n>>>\nExample7: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample8: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample9: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample10: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample11: The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\nTRFs set: ['cells', 'kinase', 'gene', 'blood', 'promoter']\n>>>\nExample12: ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\nTRFs set: ['lymphocytes', 'promonocytic', 'monocytes', 'thymocytes', 'kinase']\n>>>\nExample13: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample14: We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\nTRFs set: ['enhancer', 'gene', 'mRNA', 'genes', 'clones']\n>>>\nExample15: Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\nTRFs set: ['HeLa', 'cells', 'gene', 'genes', 'cell']\n>>>\nExample16: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .\nAnswer:\n"
    },
    {
        "idx": 1169,
        "sentence": "However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .",
        "label": {
            "SPXX motifs": "protein",
            "nuclear targeting sequence": "protein",
            "gene regulatory proteins": "protein",
            "B4-2": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample2: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample5: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample6: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample7: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample8: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample9: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample10: On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\nTRFs set: ['kinase', 'promoter', 'NF', 'enhancer', 'phosphorylation']\n>>>\nExample11: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample12: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample13: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample14: By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'cells', 'gene']\n>>>\nExample15: However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\nTRFs set: ['lymphocytes', 'thymocytes', 'blood', 'promonocytic', 'monocytes']\n>>>\nExample16: We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\nTRFs set: ['gene', 'promoter', 'genes', 'kappa', 'kinase']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .\nAnswer:\n"
    },
    {
        "idx": 1180,
        "sentence": "We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .",
        "label": {
            "IL-2R": "protein",
            "IL-2": "protein",
            "IL-2R gamma": "protein",
            "JAK3": "protein",
            "IL-2 receptor": "protein",
            "JAK1": "protein",
            "IL-2R beta": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\nTRFs set: ['kinase', 'gene', 'mRNA', 'enhancer', 'lymphocytes']\n>>>\nExample2: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample3: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample4: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample5: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample6: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample7: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample8: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample9: We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample10: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample11: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample12: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample13: Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'promonocytic', 'monocytes', 'kinase']\n>>>\nExample14: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample15: Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\nTRFs set: ['kinase', 'phosphorylation', 'promonocytic', 'mRNA', 'promoter']\n>>>\nExample16: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .\nAnswer:\n"
    },
    {
        "idx": 968,
        "sentence": "These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.",
        "label": {
            "NF-kappa B": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample2: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample3: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample4: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample5: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample8: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample9: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample10: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample11: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample12: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample13: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample14: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample15: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample16: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.\nAnswer:\n"
    },
    {
        "idx": 497,
        "sentence": "The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .",
        "label": {
            "T cells": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\nTRFs set: ['kinase', 'phosphorylation', 'kappa', 'activation', 'thymocytes']\n>>>\nExample2: In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\nTRFs set: ['mRNA', 'gene', 'genes', 'kinase', 'cells']\n>>>\nExample3: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample4: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample5: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample6: The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\nTRFs set: ['mRNA', 'thymocytes', 'lymphocytes', 'cells', 'tyrosine']\n>>>\nExample7: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample8: A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\nTRFs set: ['promoter', 'mRNA', 'genes', 'thymocytes', 'gene']\n>>>\nExample9: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample10: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample11: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample12: Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\nTRFs set: ['mRNA', 'genes', 'gene', 'promoter', 'enhancer']\n>>>\nExample13: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .\nAnswer:\n"
    },
    {
        "idx": 1606,
        "sentence": "Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .",
        "label": {
            "CD11b/CD18": "protein",
            "CD35": "protein",
            "p50/p65": "protein",
            "CR1": "protein",
            "HIV-infected monocytic cells": "cell_type",
            "complement receptors": "protein",
            "human monocytes": "cell_type",
            "NF-kappa B": "protein",
            "CR3": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample2: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample3: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample4: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample5: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample6: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample7: Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\nTRFs set: ['monocytes', 'macrophages', 'lymphocytes', 'promonocytic', 'activation']\n>>>\nExample8: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample9: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample10: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample11: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample12: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n>>>\nExample13: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample14: ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\nTRFs set: ['lymphocytes', 'promonocytic', 'monocytes', 'thymocytes', 'kinase']\n>>>\nExample15: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample16: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .\nAnswer:\n"
    },
    {
        "idx": 1653,
        "sentence": "Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .",
        "label": {
            "nonmyeloid cells": "cell_type",
            "GM-CSF": "protein",
            "PU.1": "protein",
            "GM-CSF receptor alpha promoter": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample2: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample3: CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\nTRFs set: ['macrophages', 'monocytes', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample4: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample5: In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'monocytes']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: PMA induced the expression of both CD14 and CD23 mRNA and protein.\nTRFs set: ['promonocytic', 'mRNA', 'macrophages', 'monocytes', 'promoter']\n>>>\nExample8: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample9: To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\nTRFs set: ['kinase', 'lymphocytes', 'thymocytes', 'cells', 'cell']\n>>>\nExample10: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample11: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample12: Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\nTRFs set: ['promoter', 'promonocytic', 'monocytes', 'kinase', 'cells']\n>>>\nExample13: [An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\nTRFs set: ['promonocytic', 'monocytes', 'thymocytes', 'kinase', 'cells']\n>>>\nExample14: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample15: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample16: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .\nAnswer:\n"
    },
    {
        "idx": 833,
        "sentence": "Mapping of B-cell epitopes of the human hepatitis B virus X protein .",
        "label": {
            "human hepatitis B virus X protein": "protein",
            "B-cell epitopes": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample2: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample3: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample4: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample5: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample6: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample7: T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'cells', 'macrophages']\n>>>\nExample8: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample9: The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\nTRFs set: ['gene', 'genes', 'mRNA', 'monocytes', 'promoter']\n>>>\nExample10: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample11: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample12: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample13: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample14: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample15: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Mapping of B-cell epitopes of the human hepatitis B virus X protein .\nAnswer:\n"
    },
    {
        "idx": 389,
        "sentence": "The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .",
        "label": {
            "periplasmic domain": "protein",
            "PhoQ protein": "protein",
            "cationic proteins": "protein",
            "defensin": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample2: Tat-binding protein 7 is a subunit of the 26S protease .\nTRFs set: ['kinase', 'mRNA', 'phosphorylation', 'tyrosine', 'THP']\n>>>\nExample3: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample4: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample5: Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\nTRFs set: ['mRNA', 'promoter', 'genes', 'gene', 'kinase']\n>>>\nExample6: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample7: Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\nTRFs set: ['promoter', 'mRNA', 'gene', 'enhancer', 'kinase']\n>>>\nExample8: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample9: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample10: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample11: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample12: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample13: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample14: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n>>>\nExample15: First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\nTRFs set: ['kinase', 'tyrosine', 'THP', 'mRNA', 'kappa']\n>>>\nExample16: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .\nAnswer:\n"
    },
    {
        "idx": 193,
        "sentence": "The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .",
        "label": {
            "c-myc": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample2: Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\nTRFs set: ['promoter', 'monocytes', 'kinase', 'promonocytic', 'macrophages']\n>>>\nExample3: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample4: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample5: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample6: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample7: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample8: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'lymphocytes', 'thymocytes']\n>>>\nExample9: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\nTRFs set: ['kinase', 'neutrophils', 'NF', 'phosphorylation', 'activation']\n>>>\nExample12: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample13: However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'cells', 'macrophages', 'monocytes']\n>>>\nExample14: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample15: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample16: The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'cryptococcal', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .\nAnswer:\n"
    },
    {
        "idx": 1349,
        "sentence": "Its expression was always restricted to the nucleus .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Its expression was always restricted to the nucleus .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\nTRFs set: ['mRNA', 'gene', 'promoter', 'kinase', 'genes']\n>>>\nExample2: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample3: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample4: Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\nTRFs set: ['normal', 'kinase', 'NF', 'activation', 'promoter']\n>>>\nExample5: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample6: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample7: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\nTRFs set: ['kinase', 'cells', 'lymphocytes', 'thymocytes', 'promonocytic']\n>>>\nExample8: RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\nTRFs set: ['kinase', 'RNAs', 'cells', 'promonocytic', 'promoter']\n>>>\nExample9: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample10: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample11: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'THP', 'monocytes']\n>>>\nExample12: Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'cells', 'leukocytes']\n>>>\nExample13: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample14: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample15: Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'promonocytic', 'enhancer']\n>>>\nExample16: The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\nTRFs set: ['mRNA', 'promonocytic', 'promoter', 'kinase', 'RNAs']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Its expression was always restricted to the nucleus .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Its expression was always restricted to the nucleus .\nAnswer:\n"
    },
    {
        "idx": 882,
        "sentence": "This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .",
        "label": {
            "c-Jun": "protein",
            "heterodimeric activator protein-1 transcription complex": "protein",
            "c-Fos": "protein",
            "cDNA": "DNA",
            "human c-Jun protein": "protein",
            "cDNA clone": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample2: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample3: This protein has now been purified and its encoding gene cloned.\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'clones']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\nTRFs set: ['kinase', 'mRNA', 'thymocytes', 'lymphocytes', 'cells']\n>>>\nExample6: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample7: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample8: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample9: To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\nTRFs set: ['promoter', 'enhancer', 'kinase', 'mRNA', 'promonocytic']\n>>>\nExample10: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample11: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample12: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample13: Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\nTRFs set: ['kinase', 'phosphorylation', 'clones', 'tyrosine', 'thymocytes']\n>>>\nExample14: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample15: Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\nTRFs set: ['macrophages', 'monocytes', 'mRNA', 'kinase', 'promonocytic']\n>>>\nExample16: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .\nAnswer:\n"
    },
    {
        "idx": 725,
        "sentence": "Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .",
        "label": {
            "Rex": "protein",
            "HTLV-infected cells": "cell_type",
            "gag/pol": "protein",
            "env mRNA": "RNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\nTRFs set: ['thymocytes', 'promonocytic', 'promoter', 'cells', 'mRNA']\n>>>\nExample2: We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'mRNA', 'promonocytic']\n>>>\nExample3: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample4: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample5: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample6: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample7: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample8: One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\nTRFs set: ['macrophages', 'gene', 'mRNA', 'enhancer', 'monocytes']\n>>>\nExample9: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample10: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample11: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample12: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample13: Expression of either the TCL1 oncogene , or transcripts from its homologue MTCP1/c6.1B , in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'cells', 'kinase']\n>>>\nExample14: Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\nTRFs set: ['lymphocytes', 'thymocytes', 'gene', 'genes', 'cells']\n>>>\nExample15: Finally, despite impaired Rel-A translocation , T cells were capable of transcribing IL-2 .\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'cells', 'mRNA']\n>>>\nExample16: Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\nTRFs set: ['lymphocytes', 'promoter', 'promonocytic', 'thymocytes', 'mRNA']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .\nAnswer:\n"
    },
    {
        "idx": 867,
        "sentence": "In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).",
        "label": {
            "conserved binding sites": "DNA",
            "nuclear factor kappa B": "protein",
            "long terminal repeat": "DNA",
            "LTR": "DNA",
            "NF kappa B": "protein",
            "transcriptional enhancer": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample2: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample3: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample4: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample5: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample6: The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\nTRFs set: ['mRNA', 'promoter', 'gene', 'enhancer', 'HB']\n>>>\nExample7: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\nTRFs set: ['lymphocytes', 'thymocytes', 'tyrosine', 'RNAs', 'NF']\n>>>\nExample8: We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\nTRFs set: ['enhancer', 'kappa', 'kinase', 'promoter', 'gene']\n>>>\nExample9: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\nTRFs set: ['kinase', 'tyrosine', 'promoter', 'lymphocytes', 'thymocytes']\n>>>\nExample10: We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\nTRFs set: ['kinase', 'monocytes', 'phosphorylation', 'macrophages', 'lymphocytes']\n>>>\nExample11: Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\nTRFs set: ['promoter', 'enhancer', 'kinase', 'gene', 'genes']\n>>>\nExample12: Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\nTRFs set: ['kinase', 'activation', 'tyrosine', 'lymphocytes', 'THP']\n>>>\nExample13: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample14: The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\nTRFs set: ['kinase', 'mRNA', 'promoter', 'phosphorylation', 'enhancer']\n>>>\nExample15: NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\nTRFs set: ['promoter', 'mRNA', 'enhancer', 'gene', 'NF']\n>>>\nExample16: The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region .\nTRFs set: ['NF', 'promoter', 'enhancer', 'mRNA', 'RNAs']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).\nAnswer:\n"
    },
    {
        "idx": 841,
        "sentence": "Such tests may become useful diagnostic tools .",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Such tests may become useful diagnostic tools .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample2: In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.\nTRFs set: ['promonocytic', 'lymphocytes', 'monocytes', 'macrophages', 'mRNA']\n>>>\nExample3: In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\nTRFs set: ['lymphocytes', 'blood', 'cells', 'monocytes', 'thymocytes']\n>>>\nExample4: In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'endobronchial', 'gene']\n>>>\nExample5: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample6: Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\nTRFs set: ['kinase', 'lymphocytes', 'promonocytic', 'promoter', 'thymocytes']\n>>>\nExample7: Additionally, mutated Ras can also serve as a primary target for the development of immunotherapy or drug therapy .\nTRFs set: ['kinase', 'gene', 'tyrosine', 'genes', 'cells']\n>>>\nExample8: By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\nTRFs set: ['gene', 'cells', 'mRNA', 'genes', 'lymphocytes']\n>>>\nExample9: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample10: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample11: This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\nTRFs set: ['gene', 'mRNA', 'genes', 'promoter', 'lymphocytes']\n>>>\nExample12: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample13: By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\nTRFs set: ['clones', 'gene', 'genes', 'cells', 'phosphorylation']\n>>>\nExample14: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample15: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample16: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Such tests may become useful diagnostic tools .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Such tests may become useful diagnostic tools .\nAnswer:\n"
    },
    {
        "idx": 956,
        "sentence": "BSAP : a key regulator of B-cell development and differentiation .",
        "label": {
            "BSAP": "protein",
            "B-cell": "cell_type"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'BSAP : a key regulator of B-cell development and differentiation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\nTRFs set: ['enhancer', 'phosphorylation', 'kinase', 'promoter', 'promonocytic']\n>>>\nExample2: These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\nTRFs set: ['lymphocytes', 'thymocytes', 'cells', 'activation', 'cell']\n>>>\nExample3: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample4: A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\nTRFs set: ['promoter', 'thymocytes', 'lymphocytes', 'kinase', 'THP']\n>>>\nExample5: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\nTRFs set: ['mRNA', 'kinase', 'gene', 'promoter', 'genes']\n>>>\nExample6: The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\nTRFs set: ['kinase', 'phosphorylation', 'tyrosine', 'thymocytes', 'lymphocytes']\n>>>\nExample7: Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .\nTRFs set: ['thymocytes', 'lymphocytes', 'kinase', 'cells', 'THP']\n>>>\nExample8: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample9: Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'cells', 'blood']\n>>>\nExample10: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample11: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample12: The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'cell']\n>>>\nExample13: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample14: New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\nTRFs set: ['kinase', 'lymphocytes', 'NF', 'neutrophils', 'promonocytic']\n>>>\nExample15: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\nTRFs set: ['lymphocytes', 'kinase', 'thymocytes', 'leukocytes', 'cells']\n>>>\nExample16: Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\nTRFs set: ['kinase', 'lymphocytes', 'promonocytic', 'promoter', 'thymocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'BSAP : a key regulator of B-cell development and differentiation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: BSAP : a key regulator of B-cell development and differentiation .\nAnswer:\n"
    },
    {
        "idx": 1769,
        "sentence": "We have tried to find out whether these receptors could show any difference in sex or age distribution.",
        "label": {},
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have tried to find out whether these receptors could show any difference in sex or age distribution.'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\nTRFs set: ['monocytes', 'macrophages', 'promonocytic', 'kinase', 'phosphorylation']\n>>>\nExample2: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample3: We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3 .\nTRFs set: ['enhancer', 'promoter', 'kinase', 'mRNA', 'HeLa']\n>>>\nExample4: Human cDNAs encoding subunits of these factors have been cloned and sequenced.\nTRFs set: ['mRNA', 'genes', 'gene', 'clones', 'RNAs']\n>>>\nExample5: Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .\nTRFs set: ['gene', 'enhancer', 'genes', 'mRNA', 'promoter']\n>>>\nExample6: Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\nTRFs set: ['kinase', 'tyrosine', 'kappa', 'phosphorylation', 'activation']\n>>>\nExample7: Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .\nTRFs set: ['cells', 'cell', 'kinase', 'promonocytic', 'phosphorylation']\n>>>\nExample8: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample9: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample10: We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\nTRFs set: ['kinase', 'mRNA', 'cell', 'gene', 'cells']\n>>>\nExample11: We also found that the deviation of methylation in granulocytes and T cells was well correlated.\nTRFs set: ['thymocytes', 'lymphocytes', 'leukocytes', 'monocytes', 'promonocytic']\n>>>\nExample12: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample13: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample14: We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\nTRFs set: ['kinase', 'activation', 'enhancer', 'tyrosine', 'promoter']\n>>>\nExample15: To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\nTRFs set: ['thymocytes', 'cells', 'lymphocytes', 'mRNA', 'activation']\n>>>\nExample16: In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\nTRFs set: ['lymphocytes', 'kinase', 'activation', 'thymocytes', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'We have tried to find out whether these receptors could show any difference in sex or age distribution.'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: We have tried to find out whether these receptors could show any difference in sex or age distribution.\nAnswer:\n"
    },
    {
        "idx": 110,
        "sentence": "Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .",
        "label": {
            "long terminal repeat": "DNA",
            "NF-KB": "protein",
            "double repeat-KB enhancer sequence": "DNA",
            "cellular transactivation factor": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\nTRFs set: ['kinase', 'lymphocytes', 'phosphorylation', 'monocytes', 'promoter']\n>>>\nExample2: Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\nTRFs set: ['kinase', 'kappa', 'promoter', 'NF', 'mRNA']\n>>>\nExample3: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n>>>\nExample4: Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\nTRFs set: ['activation', 'kinase', 'NF', 'phosphorylation', 'kappa']\n>>>\nExample5: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample6: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample7: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample8: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample9: One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\nTRFs set: ['kinase', 'enhancer', 'promoter', 'gene', 'genes']\n>>>\nExample10: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample11: Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\nTRFs set: ['promoter', 'enhancer', 'mRNA', 'genes', 'kinase']\n>>>\nExample12: These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\nTRFs set: ['kinase', 'phosphorylation', 'promoter', 'NF', 'FP']\n>>>\nExample13: The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\nTRFs set: ['kappa', 'kinase', 'lymphocytes', 'thymocytes', 'cells']\n>>>\nExample14: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample15: The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\nTRFs set: ['kinase', 'mRNA', 'RNAs', 'NF', 'kappa']\n>>>\nExample16: An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\nTRFs set: ['kinase', 'activation', 'promoter', 'tyrosine', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .\nAnswer:\n"
    },
    {
        "idx": 1379,
        "sentence": "Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .",
        "label": {
            "TCL1": "DNA"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample2: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample3: Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\nTRFs set: ['monocytes', 'promonocytic', 'thymocytes', 'cells', 'lymphocytes']\n>>>\nExample4: The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\nTRFs set: ['promonocytic', 'macrophages', 'monocytes', 'lymphocytes', 'leukocytes']\n>>>\nExample5: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample6: The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'cells', 'leukocytes']\n>>>\nExample7: Here we examined the regulatory mechanism of the SCM-1 genes .\nTRFs set: ['genes', 'gene', 'promoter', 'mRNA', 'kinase']\n>>>\nExample8: Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'cell', 'gene']\n>>>\nExample9: Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\nTRFs set: ['kinase', 'lymphocytes', 'promonocytic', 'promoter', 'thymocytes']\n>>>\nExample10: SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\nTRFs set: ['kinase', 'lymphocytes', 'cells', 'promonocytic', 'thymocytes']\n>>>\nExample11: To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\nTRFs set: ['mRNA', 'promonocytic', 'lymphocytes', 'gene', 'thymocytes']\n>>>\nExample12: TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'blood', 'patients']\n>>>\nExample13: This review suggests roles for these alterations in the development of lymphoid neoplasms .\nTRFs set: ['lymphocytes', 'thymocytes', 'leukocytes', 'neutrophils', 'promonocytic']\n>>>\nExample14: Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\nTRFs set: ['kinase', 'phosphorylation', 'lymphocytes', 'promonocytic', 'thymocytes']\n>>>\nExample15: Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\nTRFs set: ['kinase', 'thymocytes', 'promoter', 'cells', 'lymphocytes']\n>>>\nExample16: Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\nTRFs set: ['kinase', 'leukocytes', 'activation', 'phosphorylation', 'lymphocytes']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .\nAnswer:\n"
    },
    {
        "idx": 1338,
        "sentence": "The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .",
        "label": {
            "Bcl-2 family": "protein",
            "cellular proteins": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\nTRFs set: ['kinase', 'kappa', 'NF', 'promoter', 'phosphorylation']\n>>>\nExample2: Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\nTRFs set: ['promonocytic', 'cells', 'promoter', 'macrophages', 'thymocytes']\n>>>\nExample3: Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\nTRFs set: ['kinase', 'phosphorylation', 'activation', 'kappa', 'NF']\n>>>\nExample4: We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\nTRFs set: ['neutrophils', 'kinase', 'macrophages', 'phosphorylation', 'monocytes']\n>>>\nExample5: Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\nTRFs set: ['kinase', 'thymocytes', 'promonocytic', 'cells', 'lymphocytes']\n>>>\nExample6: The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\nTRFs set: ['kinase', 'cells', 'phosphorylation', 'cell', 'macrophages']\n>>>\nExample7: Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\nTRFs set: ['leukocytes', 'lymphocytes', 'neutrophils', 'promonocytic', 'blood']\n>>>\nExample8: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample9: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample10: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\nTRFs set: ['lymphocytes', 'thymocytes', 'promonocytic', 'cells', 'macrophages']\n>>>\nExample11: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample12: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\nTRFs set: ['kinase', 'activation', 'cell', 'phosphorylation', 'cells']\n>>>\nExample13: There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\nTRFs set: ['lymphocytes', 'kinase', 'gene', 'genes', 'mRNA']\n>>>\nExample14: The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\nTRFs set: ['kinase', 'cells', 'promoter', 'cell', 'activation']\n>>>\nExample15: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\nTRFs set: ['lymphocytes', 'thymocytes', 'activation', 'kinase', 'promoter']\n>>>\nExample16: The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\nTRFs set: ['phosphorylation', 'tyrosine', 'kinase', 'mRNA', 'THP']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .\nAnswer:\n"
    },
    {
        "idx": 1323,
        "sentence": "PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .",
        "label": {
            "PRE-I": "DNA",
            "Jurkat cells": "cell_line",
            "multiple DNA-protein complexes": "protein"
        },
        "stage1": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .'\nWhat entity types may be included in this sentence?\nIf not present, answer: None.\nRespond as a list, e.g. ['entity type 1', 'entity type 2', .....]\n",
        "stage2": "Here provide some example sentences and the corresponding TRFs. TRFs means Type Related Features, which are tokens that are strongly associated with the entity types within these sentences.\nPlease identify the TRFs in the target sentences.\nProvide answer in the following list format: ['TRF_1','TRF_2',...]\n>>>\nExample1: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\nTRFs set: ['lymphocytes', 'thymocytes', 'enhancer', 'cells', 'promonocytic']\n>>>\nExample2: Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\nTRFs set: ['lymphocytes', 'clones', 'thymocytes', 'gene', 'kinase']\n>>>\nExample3: We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\nTRFs set: ['gene', 'mRNA', 'genes', 'cells', 'enhancer']\n>>>\nExample4: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\nTRFs set: ['promoter', 'kinase', 'phosphorylation', 'lymphocytes', 'enhancer']\n>>>\nExample5: A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\nTRFs set: ['mRNA', 'enhancer', 'gene', 'kinase', 'RNAs']\n>>>\nExample6: Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\nTRFs set: ['mRNA', 'kinase', 'cells', 'RNAs', 'promoter']\n>>>\nExample7: We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\nTRFs set: ['kinase', 'promoter', 'enhancer', 'phosphorylation', 'kappa']\n>>>\nExample8: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\nTRFs set: ['monocytes', 'promonocytic', 'macrophages', 'kinase', 'promoter']\n>>>\nExample9: Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\nTRFs set: ['kinase', 'promoter', 'activation', 'enhancer', 'phosphorylation']\n>>>\nExample10: Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\nTRFs set: ['kinase', 'kappa', 'activation', 'phosphorylation', 'cells']\n>>>\nExample11: The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\nTRFs set: ['kinase', 'kappa', 'promoter', 'gene', 'lymphocytes']\n>>>\nExample12: Expression of Tip and Tap in Jurkat-T cells induced dramatic cell aggregation.\nTRFs set: ['cells', 'thymocytes', 'cell', 'kinase', 'Jurkat']\n>>>\nExample13: Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\nTRFs set: ['mRNA', 'promoter', 'kinase', 'RNAs', 'lymphocytes']\n>>>\nExample14: Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\nTRFs set: ['kinase', 'mRNA', 'gene', 'Jurkat', 'promoter']\n>>>\nExample15: Expression of tal-1 and GATA-binding proteins during human hematopoiesis .\nTRFs set: ['thymocytes', 'kinase', 'blood', 'genes', 'mRNA']\n>>>\nExample16: NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\nTRFs set: ['promoter', 'mRNA', 'enhancer', 'gene', 'NF']\n",
        "stage3": "Given entity label set: ['DNA', 'RNA', 'cell_type', 'protein', 'cell_line'] and target sentence : 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .'\nConsider the above TRFs, recognize the named entities for the target sentence.\nProvide answer in the following JSON format: [{\\\"Entity Name\\\": \\\"Entity Label\\\"}]. If there is no entity in the text, return the following empty list: []\n\nSentence: PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .\nAnswer:\n"
    }
]